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ABSTRACT 
 
Molecular Detection and Characterization of Avian Bornavirus. (May 2011) 
Negin Mirhosseini, B.S., Kerman Shahid Bahonar University; M.S., Texas A&M 
University 
Chair of Advisory Committee: Dr. Susan Payne 
 
Proventricular dilatation disease (PDD) was first recognized during an outbreak 
among captive macaws in the late 1970s. The disease, also known as proventricular 
dilatation syndrome or macaw wasting disease can occur in any psittacine but the most 
commonly affected birds are macaws, cockatoos and conures. The disease causes 
inflammation of the central, peripheral and autonomic nervous systems, as well as 
weight loss associated with regurgitation and the passage of undigested food in the feces. 
Although a viral etiology for PDD has been suspected for almost 40 years, the etiologic 
agent of the disease was unknown until lately. Recently we cultured a novel bornavirus 
from brain tissue from birds clinically diagnosed with PDD. This finding supports data 
from other groups who, in 2008, identified bornavirus sequences among birds suffering 
from PDD. It was reported that more 60% of PDD affected birds were infected with the 
new virus, designated avian bornavirus (ABV).  ABV is a negative sense, single 
stranded RNA virus related to Borna disease virus (BDV). ABV isolates differ 
dramatically from BDV isolates in their level of genetic variation. Using polymerase 
chain reaction (PCR) assays, we were able to detect ABV in feces and tissue of PDD 
birds.  We also detected ABV shedding from clinically healthy birds housed in aviaries 
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with no history of the disease. We also determined the complete genome sequences of 
eight North American ABV isolates. Genotyping indicates that the majority of North 
American ABV isolates are genotype 4. We found one ABV, genotype 1, which is the 
first complete sequencing of this genotype. Moreover, we found ABV genotype 2, 
isolated from an apparently healthy cockatiel with no PDD clinical signs. In order to 
investigate whether this genotype is avirulent, the virus was grown in duck embryo 
fibroblasts and inoculated into two adult cockatiels by the oral and intramuscular routes.  
One bird developed clinical signs on day 33 and was euthanized on day 36. The second 
challenged bird developed clinical signs on day 41 and was euthanized on day 45. On 
necropsy, the proventriculus of both birds was slightly enlarged and microscopic 
examination showed lesions consistent with PDD in the brain, spinal cord, heart, adrenal 
gland and intestine.  A control, uninoculated cockatiel was apparently healthy when 
euthanized on day 50. ABV2 is now the second ABV genotype to be formally shown to 
cause PDD.  
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CHAPTER I 
INTRODUCTION: PROVENTRICULAR DILATATION DISEASE 
AND THE DISCOVERY OF AVIAN BORNAVIRUSES 
Proventricular Dilatation Disease (PDD) 
History  
In 1979, proventricular dilatation disease (PDD) was initially described in 
macaws. At that time the disease was called “macaw wasting or fading syndrome”, 
“wasting macaw syndrome”, and “gastric distension of macaws” (28). As the disease 
was reported in other psittacines more general terms such as “proventricular dilatation”, 
“proventricular dilatation syndrome”, “proventricular hypertrophy”, “proventricular 
dilatation of macaws or psittacines”, and “proventricular dilatation disease” were used 
(28). Discoveries into possible causes of the disease generated names that reflected the 
pathologic signs such as  “neuropathic gastric dilatation of psittaciformes”, 
“proventricular and ventricular myositis”, “myenteric ganglioneuritis”, and “psittacine 
encephalomyelitis” (28).   
To date PDD has been reported to affect more than 50 species of psittaciformes, 
including members of the Cacatuidae (i.e., cockatoos and cockatiels) and Psittacidae 
(i.e., lovebirds, macaws, parakeets, parrots, Amazon parrots, and conures) families (28).  
 
 
____________ 
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While PDD was first described in the United States, it is now a well-known and 
established disease of captive psittacines in the United States, Canada, the United 
Kingdom, Europe, and Australia (18). 
Clinical Signs 
PDD causes inflammation of the central, peripheral, and autonomic nervous 
systems. The clinical signs of PDD may vary to some extent between individuals and 
species. Clinical laboratory findings are usually inconclusive and may include signs of 
gastrointestinal dysfunction such as hypoproteinemia and hypoglycaemia or signs of 
opportunistic infections such as heterophilia. There are two general syndromes that birds 
may exhibit: neurological and gastrointestinal. Some PDD birds exhibit only 
neurological signs, others exhibit only gastrointestinal signs and some birds display both 
neurological and gastrointestinal involvement. Neurological signs are related to effects 
on the central nervous system (CNS) and include, but are not limited to, ataxia, 
blindness, abnormal head movements, and seizure. Affected birds tend to lose their 
balance and may become paralyzed. Development of gastrointestinal signs are caused by 
paralysis of the proventriculus and include weight loss (associated with regurgitation and 
the passage of undigested food in the feces), proventricular enlargement, diarrhea, 
weakness, and starvation (65). 
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Diagnosis 
A presumptive diagnosis of PDD is based on history, clinical signs, radiographic 
evidence of dilatation of proventriculus as well as duodenum descendens and extended 
transit times of ingestions, fluoroscopic evidence of gastrointestinal dysfunction, and the 
histopathological examination of biopsy specimens. Definitive diagnosis is based on the 
demonstration of characteristic lymphoplasmacytic infiltrates within autonomic nerves 
and ganglia at various levels in the digestive tract (1, 65). The most reliable location of 
infiltrates has been shown to be the ventriculus (93%) and heart (79%). Unfortunately 
biopsy is invasive and potentially fatal in debilitated birds (29). Another common 
diagnostic procedure, which is less invasive and risky, is to perform crop biopsy to look 
for the lymphocytic infiltration of nerves of the crop. However crop biopsy is not a 
sensitive indicator of PDD as in a study of 44 birds with clinical diagnosis of PDD, only 
30 showed infiltrates in crop biopsies with no clear pattern of the infiltrates‟ location 
(31). Historically there have been no cases with infiltrates present in crop without 
concomitant lesions in the proventriculus or ventriculus. As crop biopsies are not done 
on healthy birds, these so-called healthy birds cannot be guaranteed to be free of PDD. 
Prognosis 
The prognosis of PDD affected birds is poor and no specific treatment is 
available at this time (42).  However symptomatically treating the affected birds by 
using anti-inflammatory drugs reduces inflammation of the central and peripheral 
nervous system as well as the digestive system. Use of anti-inflammatory drugs, in 
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conjunction with antimicrobials to control secondary infections, can help extend survival 
for months to years (20, 42).  
The Etiology of PDD 
There has been much speculation as to the cause of PDD. Evidence of 
transmissibility was obtained when healthy birds, receiving the tissue homogenates from 
diseased birds, developed both clinical symptoms and histopathological lesions 
associated with PDD (30). With no evidence of bacterial infection a viral etiology was 
suspected and several viral candidates were implicated. The first candidate for a viral 
etiology of PDD was a paramyxovirus related to Newcastle disease (32). This 
speculation was based upon observing, by transmission electron microscopy, inclusion 
bodies and enveloped virus-like particles of 30 to 250 nm in size in the myenteric plexus 
and celiac ganglion of affected birds. However, serological studies did not support the 
observation, as paramyxovirus-specific antibodies were not found in diseased birds (39). 
Many other viruses such as coronaviruses (25), equine encephalitis virus, avian herpes 
virus, polyomaviruses, adeno-like viruses, enteroviruses, reoviruses, and avian 
encephalitis virus were, at one time or another, implicated as etiologic agents of PDD 
(65). In view of the fact that no potential viral agents could be clearly linked to PDD it 
was proposed that the disease might be autoimmune in nature and initiated by virus 
infection or gangliosides (65).  
Even though the etiology of PDD was unclear until recently, isolation of affected 
birds was recommended. This suggestion was originally based on the observation of 
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PDD outbreaks in aviaries, the demonstration that PDD could be transmitted 
experimentally, and the identification of virus-like particles in tissues and feces of birds 
affected by PDD (65). 
In 2008 and 2009, advanced technologies using fast and unbiased searches for 
viruses in clinical specimens identified novel Borna disease-like viruses associated with 
PDD (34, 39). Honkavuori et al. identified at least 2 different bornavirus strains in brains 
from 3 PDD birds (34). RNA extracted from brain tissue of parrots with PDD was 
reverse transcribed and directly subjected to high throughput sequencing. By searching 
for sequence similarities to known viruses, the group found genetic material with 
striking similarity to Borna disease virus (BDV) (34). In an independent study Kistler et 
al. also found evidence of bornaviruses in 62% of PDD cases. In this study, RNA 
extracted from parrots with PDD was hybridized to a pan-viral microarray that carried 
multiple cDNA probes from known viruses. The initial finding was confirmed using 
high throughput sequencing (39). Subsequent studies have provided additional support 
for avian bornavirus (ABV) as the etiological agent of PDD. Ouyang et. al (47) used an 
antiserum directed against the ABV nucleoprotein (N-protein) to perform 
immunohistochemistry and observed that 13 out of 13 cases of PDD contained ABV N-
protein in their CNS while only one out of 11 reportedly negative cases contained this 
protein (47).  In another study, the clinical and pathological signs of PDD were induced 
by inoculation of cockatiels via multiple routes (intramuscular, intraocular, intranasal, 
and oral) with brain homogenates derived from an ABV-infected bird (21). In a more 
defined study ABV was isolated from the brain of a PDD positive bird and passed in 
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duck embryo fibroblasts (DEF).  The ABV infected cells were administered via oral and 
intramuscular routes to two healthy Patagonian conures and classical PDD was induced 
in these two birds by 66 days post-infection (26). 
Epidemiological surveys also support the association of ABV with PDD.  In one 
study, ABV was present in 71% of parrots with PDD and was absent in healthy animals 
(39). Other studies reported similar results, with detection of ABV in most, but not all, 
parrots with clinically suspected PDD (65). Given the known divergence among ABV 
strains identified to date (39), the inability of molecular or serological methods to detect 
ABV in some suspected cases of PDD might be due to strain differences although it 
cannot be ruled out that a second unrelated virus causes a similar disease.  
Although there is a strong correlation between ABV infection and PDD, 
questions remain concerning routes of natural infection and transmission. It is not 
uncommon for birds exposed directly or indirectly to an affected bird to remain 
asymptomatic (28). For example, in a group of mixed species of wild-caught psittacine 
birds exposed to a bird confirmed by histopathology to have PDD, signs of the disease 
were not noted in any of the contact birds for up to a year following exposure (29). This 
might suggest innate resistance in some birds.  
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Bornaviruses 
Borna Disease Virus (BDV) 
BDV was the only known member of the family Bornaviridae, until the 
relatively recent discovery of avian bornavirus (ABV). BDV is a noncytolytic, 
enveloped RNA virus that most commonly affects horses and sheep in central Europe. 
The virus is highly neurotropic and infects the central, peripheral, and autonomic 
nervous systems (36). Thus a detailed examination of BDV may provide a better 
understanding of ABV and aid in predicting its structure and life cycle as well as aid in 
designing experiments in to enhance our knowledge of this virus.  
Bornaviruses are non-segmented negative strand (NNS) RNA viruses (11) 
belonging  to the family Bornaviridae (order Mononegavirales) whose prototype 
member is BDV (36).  The BDV genome is approximately 9.9 kb which is significantly 
smaller than Paramyxoviridae (approximately 16 kb) or Filoviridae (approximately 19 
kb) and quite similar to the Rhabdoviridae (approximately 11±1.5 kb)(36). BDV 
sequences obtained from various species have shown extraordinary sequence 
conservation uncommon amongst the RNA viruses (36). It has been suggested that the 
virus has a high degree of genetic adaptation to non-cytolytic replication in the CNS and 
restricted genetic flexibility (62). Comparison of nucleoprotein and phosphoprotein 
coding regions among widely distinct BDV isolates reveals variability of up to 4.1% at 
the nucleotide sequence level and 1.5% to 3% at the predicted amino acid level (36). 
Recently a new BDV genotype (designated No/98), which is 15% divergent in 
nucleotide sequence from other BDVs, was isolated from a naturally infected horse in 
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Austria (36) hinting that BDV sequences may be more genetically variable than 
previously recognized, an idea that is now supported by the genomic divergence seen 
among avian bornaviruses (39). 
Virion Morphology and Physical Characteristics 
 Using electron microscopy, BDV infectious particles appear to have a spherical 
morphology with a diameter ranging from 70 to 130 nm, covered with spikes 
approximately 7 nm long (14, 43). However, since BDV is very cell associated, it has 
been difficult to characterize particles any further. Virions or particles have not been 
seen in infected tissue. Virions are stable at 37ºC and at 4ºC; infectivity is stable for 
more than 3 months. Infectivity is lost at a pH below 5 or above 12 and by heat treatment 
at 56ºC. Organic solvents, detergents, formaldehyde, and exposure to ultra violet 
radiation also inactivate virus infectivity (14, 43). 
Genome Organization and Encoded Proteins 
The BDV genome is organized into three transcription units (I, II, III) defined by 
three transcription initiation signals (S1–S3) and four transcription termination signals 
(T1-T4) which encode at least six open reading frames (ORFs) (Fig. 1)(36). BDV 
polypeptides, with the exception of N, are translated from polycistronic mRNAs (4). 
Hence, unlike other members of the order Mononegavirales that have open reading 
frames clearly separated by adjacent termination and transcription start signals, BDV 
transcription units and transcription signals overlap (13, 62). The first transcription unit 
 9 
starts at position +44 (or 32) from the genomic 3‟-end and encodes the Nucleoprotein 
p40 (N). The second transcription unit contains overlapping ORFs for p10 (X) and the 
p24 phosphoprotein (P). The third transcription unit contains overlapping ORFs for the 
matrix protein (M), the glycoprotein (G), and the L- polymerase (L) (36, 62). In the case 
of mutlicistronic mRNAs, expression of downstream proteins can be obtained by a leaky 
ribosome-scanning mechanism, recommencement of scanning after termination of an 
upstream ORF, or cap-independent internal initiation (4). 
Nucleoprotein  
The BDV nucleoprotein has two isoforms, p40 and p38. The in vivo significance 
of the two isoforms is unknown. While p40 is derived from the full length ORF, p38 
translation starts at the second in-frame AUG codon, thus lacks 13 amino acids at the 
amino terminus. The two isoforms may also be encoded by two different mRNA species 
(40). There is a nuclear localization signal (NLS) in the first 13 amino acids of p40 
resulting in its nuclear localization whereas p38 primarily localizes to the cytoplasm. 
Both N isoforms have an internal leucine-rich motif, L128TELEISSIFSHCC141, which is 
a nuclear export signal (NES). Both isoforms bind the viral P protein and to RNA to 
form ribonucleoprotein (RNP) complexes. Interestingly, the NES region of N overlaps 
the site of interaction with P and it has been shown that the nuclear export activity of 
p38N is blocked by co-expression of P. These results suggest that BDV N plays a key 
role in the nucleocytoplasmic transport of RNP complexes in combination with other 
viral proteins such as P (40, 43, 67). The nucleoprotein (p40) is also a major target for 
CD8+-T-cell-mediated immune response (52). 
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Fig. 1 Structure of the BDV genome. The BDV genome is organized into three transcription 
units (I, II, III) defined by three transcription initiation signals (S1–S3) and four transcription 
termination signals (T1-T4) which encode at least six open reading frames (ORFs). N, 
nucleoprotein; X, protein X; P, phosphoprotein; M, putative matrix protein; G, glycoprotein; L, 
polymerase. 
 
X Protein 
The smallest transcript of BDV encodes the X and P proteins. The X ORF begins 
49 nucleotides upstream from P ORF and overlaps the 71 N-terminal codons of P in a 
different reading frame (67). The 10-kDa X protein is present in both nuclear and 
cytoplasmic locations and binds directly or indirectly to P and N. The function of X is 
unclear, however through binding to P, X gains nuclear localization where it may play a 
role in negative regulation of BDV polymerase activity (54). Moreover, it has been 
recently shown that X represents the first mitochondrion-localized protein of an RNA 
virus and that it inhibits apoptosis in cultured cells and infected animals (53).  
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Phosphoprotein 
The second transcription unit of BDV also encodes a 24-kDa phosphoprotein, P. 
P has two proline containing NLS, P29RPRKIPR36 and P181PRIYPQLPSAPT193 that are 
found in the amino and carboxyl termini of P (10). It has been shown that P interacts 
with X, N, and L, as well as itself. While the interaction of P with X, N, and itself occurs 
at non-overlapping regions, the region mediating homo-oligomerization was found to 
overlap with the region of interaction with L (43, 67).  Oligomerization of P is necessary 
for polymerase activity based on assays of mutants that could interact with L but that had 
lost the ability to homo-oligomerize. P is phosphorylated at serine residues by cellular 
kinases, and phosphorylation influences its ability to form homomultimers, bind other 
viral proteins, and serve as a transcriptional activator (43, 67).  
Matrix Protein 
The M protein of BDV is a 16 kDa protein that oligomerizes and stably forms 
tetramers and octamers. M has been co-purified with N and colocalized with other 
nucleocapsid proteins, including P, suggesting the association of M with viral RNPs. 
Moreover, it has been shown that M binds to P but not N and does not inhibit viral 
transcription. Therefore, M binds to RNPs without inhibiting the viral polymerase (5).  
Glycoprotein 
The BDV G gene expresses a precursor polypeptide with a calculated molecular 
mass of 56 kDa. As a result of posttranslational modification by N-glycosylation with 
high-mannose oligosaccharides, the G precursor (gp94) migrates with a mass of 84 to 94 
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kDa. Cleavage by the cellular protease furin yields GP-1and GP-2 that correspond to the 
N- and C-terminal regions, respectively, of gp94. While gp94 accumulates in the 
endoplasmic reticulum, the GP-1 product is transported to the plasma membrane where 
it is anchored through its C-terminal transmembrane domain (8, 43). Antibodies to BDV 
gp94 exhibit neutralizing activity, suggesting that GP-1 or GP-2 or both participate in 
viral entry (24).  
RNA-dependent RNA Polymerase 
RNA-dependent RNA polymerase (RdRp) or L is a 190 kDa protein translated 
from an open reading frame generated by splicing a small upstream ORF to the large 3′ 
ORF. While the N-terminal half of the L is more closely related to rhabdoviruses, the C-
terminal half is more closely related to paramyxoviruses. Similar to other L-
polymerases, BVD- L includes RdRp motifs, is phosphorylated by cellular kinases, and 
interacts with P. Nuclear localization of L is either via its NLS motif or through a 
complex with P (43).  
Replication and Life Cycle 
As isolation and purification of ABV is not possible due to the highly cell-
associated nature of virus, thus traditional assays were not used to determine the 
replication and life cycle of BDV. Instead researchers employed various novel 
techniques and strategies to detect of the early steps of BDV replication and transcription 
(24). For example, pseudotyping experiments using recombinant vesicular stomatitis 
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virus were used to study viral entry (51) and a reverse-genetic system for BDV was 
developed (16, 50, 71). 
BDV enters cells by receptor-mediated endocytosis (24). Surface glycoproteins 
GP1 and GP2 have important roles in receptor recognition and cell entry (8, 24). Using a 
pseudotyping method, Perez and his colleagues discovered that GP1 is sufficient for 
virus receptor recognition and cell entry (51). Using a cell surface biotinylation assay 
and applying lysosomotropic agents (ammonium chloride chloroquine, and amantadine), 
allowed Gonzalez-Dunia and his colleagues to show that GP2 mediates the pH-
dependent fusion event (24). As the virus fuses to host membrane, its ribonucleoprotein 
RNP is released into the cytoplasm of infected cells (16). BDV replicates primarily in 
neurons but can infect many other tissues and organs by spreading through the axoplasm 
of peripheral nerves (16).  
Replication and transcription of the BDV genome occurs in the nucleus of 
infected cells, which is unique among the Mononegavirales. The nucleocytoplasmic 
trafficking of BDV macromolecules is mediated by NLS or NES present in these 
molecules and has an important role in the virus life cycle (16). The untranscribed 
sequences at 5‟ and 3‟ end are of the BDV genome are promoters for expression of the 
viral positive-sense antigenome and viral transcripts, and expression of the negative-
sense genome during replication, respectively. Although there is not any published data 
on regulation of BDV transcription and replication, the ratio or abundance of viral 
proteins during the replication cycle in the cell likely regulates the switch from 
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transcription to production of full length viral anti-genomes as in other Mononegavirales 
(36).  
BDV mRNAs are polyadenylated and have homogeneous and genome encoded 
5‟ ends which are thought to be 5‟ capped (16, 36). Unique among the Mononegavirales, 
BDV uses RNA splicing to regulate gene expression. RNA splicing allows BDV to 
efficiently use its genome, and may have implications for neurotropism and pathogenesis 
(16, 36). Differential splicing of the two transcription units regulates expression of the 
M, G, and L proteins. Splicing of transcription unit I places the amino acid residue in 
position 13 of the M ORF in frame with a stop codon, abolishing M expression and 
facilitating G expression. Splicing of transcription units I and II results in an mRNA 
containing the p8.3 and p190 ORFs, with the p190 ORF encoding the BDV L protein. 
Moreover, splicing of transcription unit III encodes two new viral proteins with 
predicted molecular masses of 8.4 and 165 (p165) kDa. The p165 is a truncated form of 
the BDV L polymerase (13, 16, 36).  
Cell Tropism of BDV 
A variety of cell lines derived from organs and tissues of different species such 
as MDCK (Madin-Darby Canine Kidney cells), MDBK (Madin-Darby Bovine Kidney 
cells), Vero (African green monkey kidney epithelial cells), CrFK (Crandel Feline 
Kidney cells), C6 (rat glial cells), OL (mouse oligodendrocyte cells), PC12 (rat 
phaeochromocytoma cells), SK-N-SH (human neuroblastoma cell line) and 293 (human 
embryonic kidney cells) support the replication of BDV (67). BDV can establish 
 15 
persistent infection without any cytopathic effects in the cultured cells, therefore infected 
cells cannot be distinguished from uninfected cells by simple light microscopic 
examination (67). 
Although BDV infections are most commonly observed in horses and sheep, 
experimental infections of other mammals, such as rabbits, rats, and mice, have been 
successful (65).  BDV infection causes inflammation of the central nervous system 
(CNS) (67). In naturally infected animals, the most severe inflammation is found in the 
olfactory bulb, gyrus, caudate nucleus, and the hippocampus, while only moderate 
changes occur in the spinal cord (67). 
BDV and the Immune Response 
BDV causes severe non-purulent meningoencephalitis with massive perivascular 
and parenchymal infiltration in naturally infected animals. Monocytes, T lymphocytes 
(CD4
+
 and CD8
+
) and to a lesser extent plasma cells, form the perivascular cuff (17). 
Despite severe encephalitis, degeneration of neurons is rare in naturally infected hosts, 
although astrocytosis is commonly observed in the areas of inflammation. In 
experimentally infected rats and mice, it has been demonstrated that CD8
+
 T cells that 
recognize viral antigen play a critical role in both antiviral defense and virus-triggered 
disease (45). Virus-specific CD8
+
 T cells induced by immunization can provide 
protection from infection. However, antiviral CD8
+
 T cells can be harmful if the virus 
has infected an extensive number of cells in the CNS, as CD8
+
 T cells attack infected 
cells causing severe meningoencephalitis (65, 67). It has been hypothesized that 5‟-
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terminal genome trimming of BDV might be a strategy used by BDV to down-regulate 
replication and evade the antiviral host response (63). 
Transmission 
Intranasal infection by BDV is efficient and the olfactory bulbs of naturally 
infected horses show inflammation and edema early in the course of disease suggesting 
the olfactory route as a candidate for BDV transmission. Additionally, experimental 
infection of neonatal rats shows the presence of viral gene products and infectious virus 
in saliva, urine, and feces, which are known to be important in transmission of other 
pathogenic viruses such as lymphocytic choriomeningitis virus and Hantaviruses. 
Moreover, it has been demonstrated that normal adult rats can become infected if housed 
in cages separate from, but adjacent to those of neonatally infected rats, suggesting the 
possibility of aerosol transmission. There is also a potential for hematogenous 
transmission of BVD as its nucleic acid and proteins have been found in peripheral 
blood mononuclear cells (PBMC) (38, 60).  
Avian Bornavirus (ABV) 
In 2008 ABV was reported in association with PDD positive birds (39) and 
genome sequences were obtained using pyrosequencing (34). Shortly thereafter two 
additional ABV genomes were sequenced by a second group using ultra high throughput 
sequencing of tissues from PDD birds (39). The genome organization reported by these 
two independent research groups was highly reminiscent of BDV but the new virus 
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showed a higher degree of nucleotide divergence than previously described for BDV 
isolates. To date, five distinct ABV genotypes have been isolated in psittacine birds (39) 
and also one additional distinct genotype of ABV was identified in a canary (Serinus 
canaria) suffering from PDD-like disease (70). 
Host Range 
While PDD was first reported in captive parrots of North
 
America and Europe, it 
has now been observed in psittacines worldwide, with the spreading of disease linked to 
intensive trading (65). Even though more than 50 species of Psittaciformes have shown 
signs of PDD, most reporting of the disease has been in African gray parrots, blue and 
gold macaws, cockatoos,
 
and Amazon parrots (65). This distribution may reflect a 
population bias rather than an actual species predisposition.
 
PDD-like disease has also 
been observed in species other than psittacine
 
birds (65). Examples include a report of 
clinical
 
and pathological signs in a canary (Serinus
 
canaria), greenfinch (Carduelis 
chloris), long-wattled umbrella
 
bird (Cephalopterus penduliger), bearded barbet (Lybius 
dubius), and falcon (Falco peregrinus) as well as nonsuppurative
 
encephalitis and 
ganglioneuritis in wild Canada geese (Branta
 
canadensis) (65). Furthermore, lesions 
suggestive of PDD have been reported for toucans, honeycreepers, weaver finches, and a 
roseate spoonbill (65). 
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Detection of ABV in Captive Birds 
Molecular Detection 
Reverse transcription polymerase chain reaction (RT-PCR) has proven to be a 
robust technique to detect ABV in tissue samples, collected at necropsy, from birds with 
a diagnosis of PDD (20, 35, 59). Primers designed for conserved areas of the L, M, and 
N genes have been used to detect at least 40 ABV isolates of 5 distinct genotypes (20). 
Quantitative real-time PCR, based on primers and probes within the P gene, has also 
been used to quantify ABV in different tissues (34). ABV RNA has most often been 
detected in brain, crop, proventriculus, ventricles, and adrenal glands (57). However, the 
distribution of the virus in tissues may vary from bird to bird. Some birds may have 
ABV RNA present in most major organs, as well as in the plasma, while others show a 
more restricted distribution of virus in their tissues (57). Thus, it is important that several 
types of tissues, or at least brain and gastrointestinal tract be tested.  RT-PCR has also 
been used to detect ABV RNA ante mortem from specimens such as crop biopsy 
samples, blood, choanal and cloacal swabs, and feces (20, 35). However it appears that 
testing any one sample may not be sufficient, as preliminary data show that ABV-
infected birds shed the virus only intermittently in their saliva or feces (35). Even crop 
biopsy tissue may test negative in some patients with characteristic signs of PDD (27) as 
small biopsy samples may not contain any, or enough, nerve ganglia to make a 
diagnosis.  It may be even more significant to note that ABV sequences have been 
detected in some captive birds with no history of clinical signs (20, 35). In one of our 
studies, about 20% of purchased, apparently healthy, cockatiels were ABV positive (by 
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cloacal swabs) and one of those birds showed the presence of the virus in every tissue 
tested at necropsy (Mirhosseini, unpublished data). These findings suggest that false-
negative and false-positive results must be carefully considered when RT-PCR is used to 
detect ABV infection. 
Serological Detection 
Since animals produce a detectable amount of antibody to BDV, serology has 
been applied to its diagnosis (52). The most common tests employed for detection of 
mammalian BDV have been immunofluorescence, enzyme-linked immunosorbent assay 
(ELISA) and western blot assays using persistently infected cells, lysates of such cells, 
or cloned recombinant proteins (68). In birds western blotting has also been employed 
successfully, as the serum of PDD birds contains antibodies against the ABV 
nucleoprotein, N (52, 68). From a limited number of observations it appears that a 
detectable antibody response may develop late, with respect to infection, with antibody 
predicting development of clinical PDD signs (35, 68). On the other hand we have also, 
on occasion, detected ABV antibody in apparently healthy birds (35, 68).      
Comparison of ABV and BDV 
 Generally, ABV strains show about 65% nucleotide sequence identity with BDV 
(39). However the gene order as well as the structure of transcription initiation and 
termination signals and the location of splice donor and acceptor sites are well conserved 
(39). Thus the first predicted transcription unit encodes the nucleoprotein (N), the second 
predicted transcription unit encodes the regulatory protein (X) and polymerase co-factor 
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(P), and the third transcription unit is predicted to code for matrix protein (M), surface 
glycoprotein (G) and polymerase (L) (39). Similar to BDV, ABV X and P are encoded 
from overlapping reading frames and the primary transcript of the third transcription unit 
is likely formed by splicing (39). Additionally, ABV has been found to have a high 
degree of sequence conservation in the terminal non-coding and intergenic regions of the 
viral genomes, as seen in BDV (39). The region between the N and X gene in ABV is 
shorter than in BDV, lacking a 22-nucleotide fragment that serves a regulatory function 
for the expression of the viral proteins X and P. The absence of these elements in ABV 
suggests that fine-tuning of the X protein expression may be achieved by other means in 
ABV-infected cells (39, 59, 65). 
While BDV is reported to exhibit a high preference for the CNS in naturally or 
experimentally infected animals, RT-PCR data and the results of immunohistochemistry 
show that ABV is present in many, if not all organs, of PDD positive birds (26, 48, 59). 
Immunohistochemical analyses revealed the presence of ABV antigens in intestinal villi, 
epithelial cells, lamina propria cells and myocytes supporting the conclusion that ABV 
can productively infect non-neuronal cells (59). In contrast with BDV, ABV does not 
appear to be well adapted for growth in cell lines of mammalian origin such as Vero 
cells or MDCK cells.  Instead, ABV has a high preference for avian cells in tissue 
culture. The quail fibroblast cell line CEC32, the quail skeletal muscle cell line QM7 and 
DEF are suitable for the isolation of ABV (26). 
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CHAPTER II 
PCR-BASED SCREENING FOR AVIAN BORNAVIRUS DETECTION 
Introduction 
To advance research into this devastating disease, a group of donated PDD 
positive birds were assembled in the aviary of the Schubot Exotic Bird Health Center at 
the College of Veterinary Medicine and Biosciences at Texas A&M University 
beginning in 2007. Moreover, local veterinarians were encouraged to send samples from 
birds that died of PDD. To identify the virus associated with PDD, two approaches, virus 
culture and serology, were initially used. In an attempt to grow the virus, chicken eggs 
and duck embryo fibroblasts (DEF) were inoculated with sera and tissues from PDD 
positive birds. Immunofluorescence of infected DEF and immunohistochemical staining 
of brain of PDD positive birds indicated the growth of an infectious agent (69). 
Subsequently proteins believed to be viral antigens, were identified using sera from PDD 
birds in western blot analyses. However, our efforts to purify or visualize virus particles 
had not been successful when, in 2008, both Honkavuori and colleagues (34) and Kistler 
and colleagues (39) identified Borna disease virus-like sequences in PDD positive birds 
using high throughput sequencing and hybridization methods. These breakthroughs 
enabled us to use polymerase chain reaction (PCR) assays to look for similar sequences 
and viruses in tissues from PDD birds as well as in cultures inoculated with brains of 
PDD positive birds.  
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PCR is an advanced molecular technique which can be used to diagnose 
infectious diseases with high sensitivity and ease (58). The power of PCR is due to its 
ability to synthesize millions of copies of a specific gene fragment in vitro, starting with 
a very few copies of target DNA, an amount which is undetectable by other methods 
(Figure 2). The power of PCR to amplify DNA templates is easily extended to RNA 
templates, such as ABV, by simply using reverse transcriptase in the initial step. We 
initially used PCR to detect avian bornavirus sequences in DEF inoculated with brain 
tissue from PDD birds, and in brain tissues collected at necropsy from PDD birds. This 
was followed by use of PCR to detect ABV in other tissues of both naturally and 
experimentally infected birds (35). Using PCR we also detected ABV in fecal samples 
from both PDD birds and healthy birds (35). Detecting ABV in the feces of healthy birds 
was unexpected, and led us to initiate some large-scale screening of local aviaries and 
archived fecal samples.   
Materials and Methods 
Birds 
The Schubot Exotic Bird Health Center at Texas A&M University had available 
a collection of 23 psittacine birds of seven species, donated in the belief that they 
suffered from or were in close contact with cases of PDD.  The donated birds included 
two Ara chloropterus (Red-and-green Macaw), two Ara araraunae (Blue-and-yellow 
Macaw), four Psittacus erithaca (African Grey Parrot), four Ara macao (Scarlet 
Macaw), two Pionus chalcoptera (Pionus), two Ara auricollis (Yellow-Collared 
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Macaw), three Cyanoliseus patagonus (Patagonian Conure), two Nandayus nenday 
(Nanday Parakeet) and two Ara nobilis (Red-shouldered Macaw). While they remained 
in good condition these birds were a source of blood and fecal samples; tissue samples 
were collected from birds eventually requiring humane euthanasia.  In addition to the 
donated birds, fifteen apparently healthy cockatiels (Nymphicus hollandicus) were 
purchased from a single breeder.  
 
 
 
Fig. 2 PCR cycles. (1) Denaturing at 94–96 °C. (2) Annealing at ~55 to 65 °C (3) Elongation at 
72 °C. Three cycles are shown here. The first two lines represent the DNA template to which 
primers anneal that are extended by the DNA polymerase, to give DNA products, which are used 
as templates as PCR progresses. 
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Infected DEF 
DEF cell cultures were inoculated with brain tissues from PDD positive birds as 
described by Gray and colleagues (26). These cultures were maintained in Leibowitz 
L15–McCoy 5A (LM) Medium, containing 5% new borne calf (NBC) serum and 50 
µg/ml penicillin-streptomycin, until processed for RNA purification.  
Fecal Samples 
To obtain feces from birds housed in the aviary, clean paper sheets were set 
under the cage of each bird. The birds were kept under observation and as soon as a fecal 
drop fell onto the paper it was collected with a clean swab and suspended in about 500 to 
750 µl of sterile phosphate buffered saline (PBS). Alternatively, the bird was caught, a 
swab of the cloaca was performed and the swab was re-suspended in PBS. The vials 
containing fecal material were transported on ice and either immediately processed for 
RNA isolation or frozen at -80ºC.   
Tissue Collection 
Tissues from PDD positive or healthy birds were collected for ABV testing. 
Birds were humanely euthanized and upon necropsy, small pieces of different tissues 
(brain, spinal cord, heart, lung liver, proventriculus, ventriculus, spleen, crop, and 
adrenal gland among others) were immediately frozen in dry ice and stored at -80 C 
until use.  
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RNA Isolation  
Fecal sample processing: Fresh or previously frozen fecal samples, suspended in 
500–750 µl of sterile saline, were resuspended by vortexing and the solids were pelleted 
by brief centrifugation at 2100× gravity (g) in a microcentrifuge. RNA was purified from 
the supernatants using either the Ambion MagMAX™ Viral RNA Isolation Kit 
(Ambion) or the QIAamp Viral RNA Mini kit (Qiagen), according to the manufacturer‟s 
recommendations. The MagMAX Viral RNA Isolation Kit utilizes a standard method of 
disrupting samples in a guanidinium thiocyanate-based solution that rapidly releases 
viral RNA and DNA (6, 7). Paramagnetic beads with a nucleic acid binding surface are 
then added to the sample to bind to nucleic acids. The beads/nucleic acids are captured 
on magnets, and proteins and other contaminants are washed away. The beads are then 
washed again to remove residual binding solution. Nucleic acids are eluted in a small 
volume of elution buffer. The QIAamp Viral RNA Mini kit combines the selective 
binding properties of a silica gel-based membrane with the speed of microspin 
technology. Using this kit, the samples are first lysed under highly denaturing conditions 
in proprietary buffers containing guanidine salts to inactivate RNases. The samples are 
then loaded onto the QIAamp Mini spin column where the RNA binds to the QIAamp 
silica-gel membrane in the presence of chaotropic salts. After a wash step, the RNA is 
eluted, under low- or no-salt conditions in an RNase-free buffer. Both kits demand use 
of carrier RNA in their lysis solution in order to improve the binding of viral RNA to 
beads or membranes. The kits recover total nucleic acids, which means cellular DNA 
and RNA will be recovered along with the viral RNA from any samples containing cells. 
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RNA isolation from tissues or infected cell cultures: Total RNA was extracted 
from tissues or infected DEF using the RNeasy Mini Kit (Qiagen). Tissue aliquots were 
0.2 to 0.5 g pieces that were disrupted and homogenized in guanidine isothiocyanate-
containing buffer using VWR
®
 Disposable Tissue Grinders (Cat. 47732-446 or 47747-
366). To process about 10
6 
DEF cells, the growth medium was aspirated and the cells 
were washed one time with PBS. The PBS was then aspirated, and PBS containing 
0.22% trypsin was added to flasks to detach the cells from the dish. The cells were then 
pelleted by centrifuging at 300×g for 5 min. Cells were washed with PBS and pelleted 
again. Cells were then lysed in guanidine isothiocyanate-containing buffer and the lysate 
was passed through a 20-gauge (0.9 mm) needle attached to a sterile plastic syringe at 
least 5 times, or until a homogeneous lysate was achieved. Cell and tissue lysates were 
then applied to an RNeasy mini column (Qiagen), washed and eluted as described above.  
The concentration of RNA was measured using a NanoDrop
®
 ND-1000 UV-Vis 
Spectrophotometer by applying 1.5 μl of RNA. The RNA was either immediately used 
for cDNA synthesis or frozen at -80 °C for later use.  
cDNA Synthesis 
To synthesize single-stranded cDNA from total RNA, High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems) was used. Briefly the procedure was as 
follows:  A 2X Reverse Transcription Master Mix was prepared as recommended. To 
create a 1X mix, 10 μl of RNA sample, containing approximately 250 ng to 1 μg of 
RNA, was added to 10 μl of the 2X RT Master Mix. The final concentration of 
components for cDNA synthesis were as follows: 1X RT Buffer, 4mM dNTP Mix, 1X 
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RT Random Primers, 50 units MultiScribeTM Reverse Transcriptase, 20 units RNase 
Inhibitor, and 250 ng to 1 μg of RNA. The samples were then incubated at 25oC for 10 
min, followed by 37
o
C for 120 min and 85
o
C for 5 min.  The cDNA then was used for 
PCR. 
Primer Design and PCR 
The primers 1322For and 1322Rev (Table 1) were identical to those of Honkavuori 
et al. (34).  Other primers (Table 1) were designed as additional ABV sequences were 
collected in our laboratory and/or were available in Genbank (Accession No.:  
FJ169441.1, FJ169440.1, FJ620690.1, FJ603683.1, FJ002318.1, FJ002326.1, 
FJ002327.1 and FJ002317.1). Tables 1 and 2 show the list of primer sequences and PCR 
conditions that were used to detect ABV from feces, tissues or infected cell cultures. The 
final PCR reactions contained: 1X of Platinum
®
 Taq DNA Polymerase Buffer (minus 
Mg, Invitrogen), 0.2 mM of each dNTP, 1.5 mM MgCl2, 0.2 μM of each primer, 1 to 5μl 
of cDNA and 1.0 unit of Platinum
® 
Taq DNA Polymerase. The PCR products were 
analyzed by fractionation on 0.8-1% agarose gels containing 0.002% ethidium bromide 
(10 mg/ml stock) or 1X SYBR
®
 Green (Invitrogen) and were visualized under UV light.  
 
 Table 1 Primers used for detecting ABV. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Sequence names roughly based on the position in the ABV genome. 
**Tms were calculated using OligoAnalyzer 3.1 (http://www.idtdna.com/analyzer/applications/oligoanalyzer/) 
 
 
 
 
 
 
 
 
Primer Name* Bases Sequence Tm °C** Reference 
Borna 1322For 21 CAG ACA GCA CGT CGA GTG AGA 59 (39) 
Borna 1322Rev 21 AGT TAG GGC CTC CCT GGG TAT 59 (39) 
Borna 1430Rev 24 GGC TCT TGG TCT GAG ATC ATG GAA 58 This study 
Borna 5For 21 GCG GTA ACA ACC AAC CAG CAA 58 This study 
Borna 827For 20 CAG AGC ACG GGG ACA TGT TT 58 This study 
Borna 1472Rev 20 GCC CCT CTG CCT CGA TCA TA 59 This study 
Borna 1212Rev 25 GTT CAT TAG TTT GCR AAT CCR GTT A 54 This study 
Borna 1200For 25 GTA ACY GGA TTY GCA AAC TAA TGA A 54 This study 
Borna 1200For 25 GTA ACY GGA TTY GCA AAC TAA TGA A 54 This study 
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Table 2 Primer mixes and PCR conditions to detect ABV.  
Primer 
Mix  
Forward Reverse Target Region Product Size 
PCR Conditions* 
30-40 cycles 
Annealing Step Extension Step 
2 Borna 1322For Borna 1322Rev X and P genes 68 bp 55°C; 30 sec 72°C; 10 sec 
3 Borna 1322For Borna 1430Rev X and P genes 130 bp 54°C; 30 sec 72°C; 15 sec 
N Borna 5For Borna 1212Rev N gene 1200 bp 54°C; 30 sec 72°C; 1 min 
5 Borna 827For Borna 1212Rev N gene 301 bp 54°C; 30 sec 72°C; 10 sec 
6 Borna 1200For Borna 1322Rev N and X genes 200 bp 54°C; 30 sec 72°C; 10 sec 
21 Borna1322For Borna 1472Rev X and P genes 223 bp 55°C; 30 sec 72°C; 20 sec 
22 Borna 827For Borna 1472Rev N, X and P genes 645 bp 55°C; 30 sec 72°C; 40 sec 
*For all reactions the PCR conditions were as follows: Initial denaturation, 94°C for 2 min, followed by 30 to 40 cycles of 94°C,  
30 s combined with the annealing and extension conditions listed in the table, followed by a final extension of 5 min at 72°C. 
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 DNA Sequence Analysis 
PCR products were cloned into a TOPO-TA vector (Invitrogen) and individual 
clones were sequenced after transformation into E. coli. Alternatively, the PCR products 
were purified using QIAquick PCR Purification Kit (Qiagen, Cat. 28104) if only a single 
product was detected, or gel purified using QIAquick Gel Extraction Kit (Cat. 28704) 
when more than one band was obtained, according to the manufacturer‟s 
recommendations. The purified PCR products were used for direct sequencing using one 
of the primers used for the PCR. DNA sequencing reactions were performed with the 
ABI BigDye Terminator Cycle Sequencing Kit (Applied Biosystems) and sequences 
were generated with an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems). 
Sequences were assembled and aligned by using Geneious Pro 4.6.2 software 
(www.geneious.com) and Sequencher software (http://www.idmb. 
tamu.edu/gtl/sequencher.htm). 
Results 
Detecting an Association between PDD and ABV 
Infection of DEF with brain tissue from PDD birds did not show any obvious 
cytopathic effects typical of viral infection, but immunofluorescence assays using sera 
from PDD birds indicated the growth and spread of an infectious agent throughout the 
cultures (69).  In addition, proteins believed to be viral antigens were identified using 
sera from PDD birds in immunoblot assays of brain tissue homogenates (69). While 
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these assays were well controlled and provided strong evidence of a common viral agent 
in PDD birds, we were not able to visualize virus particles using electron microscopy 
(data not shown).  However, within 48 h of the first report of BDV-like sequences in the 
brains of PDD birds (34), we were able to use PCR to screen numerous infected cell 
cultures and tissues from clinically confirmed and suspected PDD cases. 
PCR was first used to determine if DEF cells inoculated with brain tissue from 
birds with a clinical diagnosis of PDD were, in fact, infected with ABV. We performed 
reverse transcription (RT) PCR on RNA isolated from infected and control DEF 
cultures. As shown in Fig. 3, using primer mix N (Borna 5 forward and Borna 1212 
reverse), a DNA fragment of the expected size (1200 bp) was readily amplified from six 
DEF cultures originally inoculated with brain tissue from six different PDD birds, but 
not from two DEF cultures inoculated with material from control birds. Sequence 
analysis of the positive PCR products revealed that they were 80 to 99% identical, at the 
nucleotide sequence level, with each other and the initial ABV sequences in deposited in 
Genbank (Table 3).  
 Table 3 Percent nucleotide identity between partial N genes from ABV isolates.  
 ABV Type 1
a
 M25 M20 AG5 M15 M10 M14 M24 06 ABV Type 4
b
 
ABV Type 1
a
  100          
M25 89.4 100         
M20 80.9 82 100        
AG5 80.9 82 99.7 100       
M15 80.9 82 99.9 99.7 100      
M10 80.9 82 99.6 99.5 99.7 100     
M14 81.1 81.7 99.6 99.6 99.7 99.6 100    
M24 81.1 81.7 95 94.8 94.7 94.5 94.5 100   
O6 81.4 81.8 94.5 94.5 94.4 94.3 94.2 99.3 100  
ABV Type 4
 b
 80.6 81.4 94 94.7 94.7 94.7 95 92.7 94.5 100 
Isolates were assigned to previously defined ABV groups by generating Neighbor-Joining trees using a 115 nucleotide region of the N gene. 
a
 ABV serotype 1 accession No. FJ002329 
b
 ABV serotype 4 accession no. FJ603687 
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Fig. 3 Cultured material from brains of PDD positive birds is ABV positive. Performing PCR using primer mix N (Borna 5For and 
Borna 1212Rev), a band of the expected size (1200 bp) was readily amplified from six DEF cultures originally inoculated with brain tissue 
from PDD birds (AG5, M14, M15, M20, M24, M25, and O6) but not from two DEF cultures inoculated with material from control birds 
(M16 and M22). 
 
AG5       M14        M15      M16     M20       M24       M25      M22       O6 
1Kb plus 
ladder 
3
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PCR was next used to detect ABV sequences in tissues of birds with a clinical 
diagnosis of PDD. Tissue samples from bird O1, a Jenday conure (Aratinga jandaya), 
were processed as described in the Materials and Methods and RNA was used for RT-
PCR to detect ABV. Figure 4 shows ABV in central nervous system samples as well as 
the proventriculus. The presence of ABV in these tissues correlates well with the 
common clinical manifestations of PDD. Sequence analysis was done to confirm that 
PCR product is ABV.  In other studies, tissues from 30 birds were tested for the presence 
of ABV.  Using PCR, ABV sequences were detected from the brains of 21 birds. Ten of 
the ABV positive brains were from birds with a clinical diagnosis of PDD. These birds 
were identified as AG5, M10, M14, M15, M19, M20, M24, M25, O6, and O1. One 
positive brain sample (CT15) was obtained from a cockatiel euthanized for health 
reasons that were not apparently PDD-related. The rest of ABV positive brain samples 
were from birds (ducks and cockatiels) that had been experimentally infected with ABV. 
More information about all birds tested for ABV is provided in Table 4.  
 
 Table 4 List of the birds checked for the presence of ABV in the CNS. 
Bird English name Scientific name ABV
a
 WB
b
 History 
AG5 African gray parrot Psittacus erithacus + + Clincal signs and crop biopsy positive 
M4 Blue & Yellow Macaw Ara ararauna - - No clinical signs 
M10 Green-wing Macaw Ara chloropterus + (-)/+* Clinical signs but crop biopsy negative 
M14 Scarlet Macaw Ara macao + + Clincal signs and crop biopsy positive 
M15 Blue & Yellow Macaw Ara ararauna + + Clincal signs and crop biopsy positive 
M16 Scarlet Macaw Ara macao - - Presented with a liver mass 
M19 Scarlet Macaw Ara macao - - Crop biopsy negative but some abnormal behavior 
M20 Blue & Yellow Macaw Ara ararauna + N/A Clincal signs and crop biopsy positive 
M21 Blue & Yellow Macaw Ara ararauna - - Clinical signs but crop biopsy negative 
M22 Blue & Yellow Macaw Ara ararauna - N/A Clincal signs and crop biopsy positive 
M24 Yellow-collared Macaw Ara auricollis + + Clincal signs and crop biopsy positive 
M25 Yellow-collared Macaw Ara auricollis + + Clincal signs and crop biopsy positive 
O1 Jenday conure Aratinga jandaya + N/A No clinical signs 
O6 Goffin's Cockatoo Cacatua goffini + + Crop biopsy positive 
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 Table 4 continued. 
Bird English name Scientific name ABV
a
 WB
b
 History 
CT15 
Cockatiel Nymphicus hollandicus + + Presented with a wing mass, crop biopsy negative  
CTI2 
Cockatiel Nymphicus hollandicus - N/A Bird was inoculated with untreated DEF; PDD negative 
CTI6 
Cockatiel Nymphicus hollandicus - - Bird was inoculated with untreated DEF; PDD negative 
CTI8 
Cockatiel Nymphicus hollandicus + N/A Infected with ABV; PDD-like lesions at necropsy  
CTI9 
Cockatiel Nymphicus hollandicus + N/A Infected with ABV; PDD-like lesions at necropsy 
CTI14 
Cockatiel Nymphicus hollandicus + N/A Infected with ABV; PDD-like lesions at necropsy 
CTI10 
Cockatiel Nymphicus hollandicus - N/A Uninfected bird; PDD negative 
CTI1 
Cockatiel Nymphicus hollandicus + N/A Infected with ABV; PDD-like lesions at necropsy 
CTI13 
Cockatiel Nymphicus hollandicus + N/A Infected with ABV; PDD-like lesions at necropsy 
PG5 
Patagonian Conure Cyanoliseus patagonus - N/A Bird was inoculated with untreated DEF; PDD negative 
PG7 
Patagonian Conure Cyanoliseus patagonus + N/A Infected with ABV; PDD-like lesions at necropsy 
PG8 
Patagonian Conure Cyanoliseus patagonus + N/A Infected with ABV; PDD-like lesions at necropsy 
CG8 
Mallards Anas platyrhincos - N/A Bird was inoculated with untreated DEF; PDD negative 
IM-duck 
Mallards Anas platyrhincos + N/A Infected with ABV; PDD negative  
IO-duck 
Mallards Anas platyrhincos + N/A Infected with ABV; PDD negative  
IP-duck 
Mallards  Anas platyrhincos + N/A Infected with ABV; PDD negative  
a  
ABV in detection in brain 
b
 Western blot using bird serum to detect antibody reactive with ABV antigens (nucleoprotein) 
* Bird was seronegative initially; after 6 months, with the development of the clinical signs of PDD, it became seropositive. 
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Fig. 4 Detection of ABV in the CNS and proventriculus. Samples of forebrain, cerebellum and 
proventriculus (Proven.) of O1 bird were PCR amplified using primer mix 22. One major band 
near 650 bp appeared in all samples.  
 
 
While ABV was always detected in brain or CNS tissue from PDD birds, the 
presence of ABV in other organs was more variable. Figure 5 shows two different 
extremes. ABV was detected in multiple tissues (heart, lung, liver, spleen, adrenal gland, 
ventriculus, kidney, and crop) from CT15, a cockatiel seropositive for ABV N antigen 
but not displaying symptoms characteristic of PDD (Fig. 5a). The CT15 results indicate 
that ABV may be present in many tissues. In contrast ABV was detected only in brain 
tissue from M19, a scarlet macaw, a bird with no history of PDD, but housed in the same 
aviary with other PDD positive birds (Fig. 5b). However the PCR assay alone cannot 
determine the specific types of cells infected in various tissues.  
1kb plus 
ladder Forebrain  Cerebellum. Proven. 
650 bp 
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Fig. 5 Detection of ABV in tissue samples. a PCR was performed using primer mix 5 on 
tissues from CT15. Brain and proventriculus from CT15 were also PCR positive, but are not 
shown in this figure. b PCR using primer mix N on a tissue from a scarlet macaw (M19) showed 
that ABV can be restricted to the CNS. Amplification of β-actin was used as a loading control in 
these assays. The DNA ladder (1kb plus) was purchased from Invitrogen. 
 
 
A 
H2O  –cDNA   lad.    Heart    Lung   Liver   Ad.G   Crop   Vent.   Kidn.  Spleen  lad. 
        –cDNA   lad.     Heart   Lung   Liver    Ad.G   Crop   Vent.   Kidn. Spleen   lad. 
Loading control: β-Actin 
B 
H2O    –cDNA      Brain        Heart    Proven.  Intestine  
1kb plus 
ladder 
Loading control: 
β-Actin 
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ABV Shedding  
To investigate the possibility that ABV is shed by PDD positive birds, fecal 
material was obtained from three African gray parrots (Psittacus erithacus), Juniper 
(AG1), Quincy (AG2), and George (AG3), housed in the Schubot aviary. These birds 
had been identified as affected with PDD, and were crop biopsy positive and sero-
positive for ABV N antigen, but were apparently healthy at the time of fecal sample 
collection. Figure 6a shows the presence of ABV in all three samples, but not in the fecal 
material from a healthy African gray parrot, Zelda (AG8). AG8 was also seronegative 
and had a negative crop biopsy.  
To check the pattern of ABV shedding from PDD positive birds, the three 
African gray parrots were monitored over a period of 15 weeks. The results showed that 
these birds shed ABV at levels detected by our PCR assay almost continuously (Fig. 6b 
and Table 5). ABV was detected at all sampling dates from AG1 and in 12 of 13 samples 
from AG2 and AG3. This study also provided information about processing of fecal 
samples for ABV. We determined that ABV sequences could be recovered from cloacal 
swabs as well as fecal swabs (Fig. 6b) and showed that ABV can be recovered after 
samples are frozen and thawed. In this study ABV was detected from frozen fecal 
material after 2 weeks.  
 
 Table 5 ABV shedding by three PDD positive African gray parrots. 
Collected date Sample type RNA Processing Date Number PCR positive 
8/5/09 Feces The same day 3/3 
2/24/09 Feces The same day 3/3 
3/2/09 Feces and cloacal The same day 3/3 
3/9/09 Feces A week later 2/3 
3/16/09 Feces The same day 2/3 
3/24/09 Feces 10 days later 3/3 
3/31/09 Feces 3 days later 3/3 
4/6/09 Feces 10 days later 3/3 
4/13/09 Feces 3 days later 3/3 
4/20/09 Feces 2 weeks later 3/3 
4/27/09 Feces A week later 3/3 
5/4/09 Feces The same day 3/3 
6/10/09 Feces 5 days later 3/3 
4
0
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In order to determine possible shedding of the virus through other sites, 
additional samples were collected from the three ABV fecal-positive African gray 
parrots.  Using RT-PCR, ABV was detected in swabs of the nares, the choana, and the 
feathers in the axilla (Fig. 6c). All choanal swabs were positive at this sampling date, 
suggesting that this may be an important site of shedding and useful for ABV diagnosis 
in captive birds that can be easily handled. Shedding of virus from the feather follicles 
was somewhat unexpected and has implications for virus spread through shed feathers.  
ABV in Healthy Birds 
We accidentally discovered that a flock of healthy cockatiels, with no history of 
PDD, contained ABV-infected birds. These cockatiels were purchased from „aviary A‟ 
for an ABV challenge study and were checked for viral shedding in preparation for that 
study. The first time fecal samples were tested, we were surprised to see that 7 out of the 
15 birds were positive for ABV (Fig. 7; lanes1–10 and 16–23). The birds were checked 
three additional times, and each time a different set of birds was ABV positive. When we 
returned to the aviary and randomly checked 24 additional cockatiels by cloacal swab, 
sixteen percent were positive for ABV (Table 6).   
To determine the extent of ABV infection among different flocks of cockatiels 
two more aviaries were checked for ABV (Table 6). One of the aviaries (aviary B) was, 
like aviary A, an “open” aviary into which new birds were frequently introduced. The 
third aviary (aviary C) was a “closed” breeding colony. In aviary B, 24 birds were 
randomly checked, and 20% of fecal samples were positive for ABV. However, in 
aviary C, we did not detect any ABV positive fecal samples.  
  
 
Fig. 6 Use of PCR for detection of ABV in 3 African gray parrots. AG1, AG2, and AG3 were all crop biopsy positive and seropositive 
for ABV. AG8 was consistently negative on PCR, serology, and crop biopsy. a Performing PCR using primer mix 21, a band of the 
expected size was readily amplified from bird feces. b Fecal samples from 3 seropositive African gray parrots. PCR results show shedding 
to be continuous (AG1) or intermittent (AG2, or AG3). c Shedding of ABV is not restricted to fecal route. PCR with primer mix 3 shows 
that the AG1, AG2, and AG3 may shed the virus from different body sites such as nares (A), choana (B), and feathers (C). 
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 Table 6 Survey of three cockatiel aviaries for ABV. 
Aviary Samples Collection date # of tested samples % positive birds 
A* cloacal swab 3/26/09 15 birds 46% 
A* cloacal swab 4/10/09 14 birds 42% 
A* cloacal swab 4/20/09 14 birds 42% 
Average of positive birds: 43% 
A** cloacal swab 4/15/09 24 fecal swab 16% 
B feces 5-14-20009 10 fecal swab 20% 
C feces   5/22/09 11 fecal swab 0% 
*Purchased cockatiels 
** Samples collected from aviary 
 
 
 
 
 
 
4
3
 
  
 
Fig. 7 PCR for the detection of ABV sequences in bird feces using primer mix 3. Lanes1–10 and 16–23: PCR products from fecal 
samples from healthy cockatiels. Lanes 11–15: PCR products from fecal samples from PDD African gray parrots. Lanes 2, 4, 11, 12, 13, 
19 and 23 show the presence of a band corresponding to the expected 131 bp fragment using primer mix 3. Lanes labeled M contain 100 
bp ladder. Lanes labeled C are negative reagent controls. The positive control (+) lane is PCR product from the brain of a PDD case. The 
high molecular weight band seen in most fecal samples is a nonspecific product. 
   C      C                 1        2     3       4         5        6       7        8        9       10                + 
   11      12      13       14      15      16     17      18      19      20       21      22     23     C 
1Kb plus 
ladder 
1Kb plus 
ladder 
4
4
 
  
45 
Comparison of PCR with Serology for the Detection of ABV 
We compared results of PCR assays with the serology from 28 birds in our 
aviary in a single study. PCR results on the fecal samples of these birds using primer mix 
3 showed that 18 out of 28 (64%) of the birds were shedding ABV. However only 6 
(33%) of the PCR positive birds were seropositive by Western blot. The other 12 (63%) 
of the fecal positive birds were seronegative. Surprisingly, 3 out of 10 (33%) PCR 
negative birds were seropositive. Only 7 out of 28 birds were both PCR negative and 
seronegative. The results of this study have been published (68) and are summarized in 
Table 7. 
 
Table 7 Comparison of western blot and PCR for detection of ABV infection. 
 Fecal PCR Positive Fecal PCR Negative Total 
Seropositive 6 (66%) 3 (33%) 9 
Seronegative 12 (63%) 7 (37%) 19 
 
 
 
Discussion 
Use of PCR for ABV Surveillance 
PDD is frequently a fatal disease in psitassines. Just recently, it has been 
discovered that ABV is associated with PDD and likely causes the disease (12, 21, 26). 
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Using PCR, we were able to identify ABV in PDD cases. While use of the PCR 
technique for disease diagnosis may appear easy and straightforward, in reality it can be 
tricky and unreliable as there are many variables that impact results. 
One obvious variable is sample collection. In terms of ease, PCR can be 
performed on fecal samples, which can be obtained without harm or stress to the birds. 
When birds are caged individually, or in pairs, fresh fecal samples, attributed to specific 
birds, can be collected. However, as shown in Fig. 7A, some birds do not shed the virus 
in fecal material at detectable levels all the time. Virus shedding is not limited to fecal 
samples and virus can be detected from other body sites such as nares, the choana, and 
the feathers. While such samples might be more reliable for detection of ABV shedding, 
they cannot be readily collected unless the birds are caged, and can also be handled 
safely (particularly important for the large macaws).  
Other variables that impact PCR results include the frequency and level of virus 
shedding and sample handling.  For example, in the healthy cockatiel study (Fig. 8 and 
Table 6) detection of ABV in fecal samples was demonstrated to be intermittent. In 
addition, PCR failed to detect ABV in 33% of ABV seropositive birds housed in the 
Schubot aviary. Given that ABV, like BDV, is a chronic infection, we assume that most 
seropositive birds are virus carriers. Thus the „false negative‟ rate of the PCR assay was 
as high as 33% among our aviary birds. Finally, while our results indicate that ABV can 
be detected from fecal samples frozen and stored at -80C, it is likely that sample 
shipping and storage conditions can contribute to degradation of viral RNA, impacting 
PCR results.  Another confounding factor to be considered is ABV genome sequence 
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variability (see Chapter 3). There is not yet a universal primer set that can detect all 
ABV isolates. Hopefully by sequencing more ABV genotypes, that problem can be 
resolved.  Taken together, the variables discussed above strongly suggest that use of 
PCR alone is inadequate for ABV diagnosis or surveillance in individual birds.  
However, as the technique is sensitive, non-invasive, inexpensive, rapid and generally 
easy to perform, PCR screening is a good method for ABV detection amongst flocks, 
where a positive result is a strong indicator of the presence of the virus among members 
of the flock. 
Serology was also used to detect ABV infection in aviary birds with suspected or 
confirmed PDD. When the results of PCR and serology in this small study were 
compared, it was clear that neither assay alone is ideal because the results were 
discordant. Among 18 PCR positive birds, 12 (66%) were seronegative.  Serology did 
detect ABV infection (past or present) in 3 of 10 (30%) PCR negative birds.  
ABV Infection of Clinically Healthy Birds 
ABV infection, as indicated by a positive PCR result may not correspond with 
PDD, as we detected ABV in „healthy‟ cockatiels in two aviaries. During single surveys 
of three aviaries, evidence of ABV infection was found in aviaries A (16%) and B (20%) 
while there was no obvious evidence of clinically ill birds in the flocks on the sampling 
dates. Among a group of purchased cockatiels, ABV was detected by PCR in 63% of 
birds that were seronegative and clinically healthy (68). However, in the case of one 
cockatiel, CT15, a bird euthanized because of a tumor in its wing and a general diagnosis 
of „poor performance‟, ABV was found in all tissues tested by PCR although gross 
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necropsy findings did not indicate PDD. Among birds donated to the Schubot aviary, 
several are PCR positive but show no signs of ill health. Finally, it has been 
demonstrated by others that healthy macaws can coexist with the virus for a long time 
without showing any noticeable clinical signs of disease (12). 
Assessing PCR False Positives or PCR Contamination 
Sensitivity of the PCR reaction makes it a powerful tool for pathogen detection. 
We checked the sensitivity and specificity of our PCR reactions at the level of cDNA for 
a single primer set and showed that this primer pair can detect as few as copies ten of 
ABV (data not shown). However, due to the sensitivity of the PCR technique some false 
positive results were observed at the initial stage of the study (data not shown). These 
were likely due to cross-contamination of samples during processing. In order to 
overcome this issue, the RNA isolation, cDNA synthesis and assembly of PCR reactions 
were performed in an isolated room that was kept free of PCR products or ABV-
sequence containing plasmids. This strategy, along with the use of multiple negative 
controls to check reagents and sample processing helped to minimize false positive 
results.  
When performing standard PCR reactions, false positive reactions can also result from 
amplification of non-ABV products of similar size to the expected products. Thus in 
order to make sure that the amplified fragments were part of ABV genome, the PCR 
products were routinely sequenced. Sequencing data showed that the majority of our 
primers were very specific for detecting ABV when the samples were obtained from 
captive psitticines.  However in a survey of hunter-harvested waterfowl samples 
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consisting largely of blue-wing teal (Anas discors), green-winged teal (A. crecca), 
northern shovelers (A. clypeata) and gadwall (A. strepera) (19) only false positive PCR 
reactions were obtained (data not shown). In some cases the DNA products were not of 
the expected size and it was not surprising when sequence analysis did not yield ABV 
sequences. However, in some instances the PCR products were of the appropriate size 
but were not viral in origin.  
 Sequence analysis of PCR products was also used as a means to detect possible 
PCR contamination. In the waterfowl survey mentioned above, where approximately 
600 RNA samples were screened for ABV sequences, 4 samples did yield PCR products 
that were ABV by sequence analysis. However closer examination showed that the 
sequences were identical to a laboratory isolate and one sample yielding ABV products 
was a negative control RNA sample. In these cases of possible (probable) laboratory 
contamination less than 1% of the overall test samples were positive. So in order to 
detect this level of contamination, at least 100 negative samples should be run.  
Tissue Tropism of ABV 
ABV was recovered from the CNS of all infected (either naturally or 
experimentally) birds, which, due to the neurotropic nature of bornavirus, was expected. 
However, our data also showed that the ABV may not be restricted to CNS but may also 
be present in other tissues. Currently, we do not have any explanation for the distribution 
of the virus in different tissues and in any case, the PCR assay on whole tissue samples 
does not provide any information about the cell types infected. In the case of BDV, 
although it has been reported that virus is restricted to the central nervous system in 
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naturally infected animals (horses and sheep), BDV-RNA was detected also in the spinal 
cord, eye, nasal mucosa, parotid gland, lung, heart, liver, kidney, bladder and ovaries of 
in naturally infected animals with clinical disease (41). In addition, BDV-specific RNA 
was detected in conjunctival fluid, nasal secretions and saliva of two naturally infected 
animals (41).  Moreover, in naturally infected white-toothed shrews, Crocidura 
leucodon, BDV was detected in most of the tissues examined, without evidence of 
pathological lesions (56). 
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CHAPTER III 
MOLECULAR CHARACTERIZATION OF AVIAN BORNAVIRUS 
GENOMES 
Introduction 
Avian bornavirus was first detected and described in 2008 by Kistler et al. (39) 
and Honkavuori et al. (34) through efforts to identify the cause of proventricular 
dilatation disease (PDD) of captive psitticines. Over the past 3 years the links between 
ABV and PDD have been confirmed in numerous studies, and Koch‟s postulates have 
been fulfilled by demonstrating that laboratory cultured ABV causes PDD (26). PDD is 
a neurological disease frequently accompanied by the development of a severely dilated 
proventriculus. It is thought that virus replication in the enteric ganglia (where virus 
antigen in readily detected) causes a failure of gut motility (59). Stasis of the 
proventriculus leads to accumulation of food, impaction, a dilated proventriculus and 
starvation. The virus also replicates in the central nervous system where it can cause a 
severe encephalomyelitis with accompanying neurologic abnormalities (26, 59) .  
Borna disease virus (BDV) is a close relative of ABV and is the prototype 
species in the family Bornaviridae. It is highly neurotropic and was first recognized as 
the etiologic agent of Borna disease among livestock, notably horses, in central Germany 
(23, 36). Characterizing BDV was challenging due to its highly cell-associated nature 
and the complete lack of cytopathic effects in cultured cells (36). Borna disease was 
recognized for at least 2 centuries before the infectious agent was cultured and 
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characterized in the latter half of the 20
th
 century (23). Most isolates of BDV are highly 
related, showing less than 5% nucleotide sequence heterogeneity.  Few reliable reports 
of the disease, or of virus isolation, originate from outside Saxony Germany, although 
serologic and molecular diagnostic surveys suggest that the virus may be very 
widespread in nature, infecting a variety of mammals, including sheep, llamas, ostriches, 
cats, and cattle (33).  
The recent discovery of ABV as a disease agent of captive parrots was achieved 
by cutting-edge high-throughput sequence analysis of brain tissue from parrots with 
PDD (34, 39). Initial findings were quickly followed by recovery and molecular 
characterization of many distinct ABV strains (39). Based on partial sequence data of 
ABV isolates recovered from a variety of captive birds it appears that ABV is much 
more diverse than BDV.  We have sequenced 8 ABV isolates from birds with a clinical 
diagnosis of PDD. These isolates were recovered from seven different species (Psittacus 
erithacus, Ara macao, Ara ararauna, Nymphicus hollandicus, Aratinga jandaya, and 
Aratinga jandaya) of psitticines. In addition, partial ABV sequences were recovered 
from numerous other isolates as part of a diagnostic service and surveillance program at 
the Schubot Exotic Bird Health Center at the College of Veterinary Medicine at Texas 
A&M University.  We compare the nucleotide and translated protein sequences of our 
ABV isolates to each other, and to the type strain of BDV.  Our data confirms the 
organization of two ABV isolates previously reported by Kistler (39) and Rinder (59). 
One of our sequenced ABV belongs to genotype 1 and we believe that this is the first 
report of a complete genome sequence for a member of this genotype.  
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Materials and Methods 
ABV Positive Birds 
Eight PDD positive birds belonging to seven species (one Psittacus erithacus 
(AG5), one Ara macao (M14), two Ara ararauna (M15 and M20), one Nymphicus 
hollandicus (CT15), one Aratinga jandaya (O1) and one Aratinga jandaya (O6) were 
used for isolation of ABV and the resulting virus isolates were completely sequenced. 
All birds but CT15 showed clinical and/or pathological signs of PDD related to the 
digestive tract (reduced body weight, diarrhea, undigested food in feces, or dilated 
proventriculus) or to the nervous system (tremor, ataxia, or convulsions) and were 
humanely euthanized. Upon necropsy, some brain samples were immediately processed 
for RNA isolation or for virus isolation in DEF. Alternatively, samples were snap frozen 
in dry ice and stored at -80 C until they were processed.   
Virus Isolation and Cell Culture  
Sections of the cerebrum and cerebellum were homogenized, minced, and then 
passed through an 18-gauge needle in Leibowitz L15–McCoy 5A (LM) complete 
medium. In instances where immediate inoculation of DEF cultures was not possible, 
frozen brain tissue was thawed in a 37 °C water bath immediately before inoculation. 
One milliliter of the brain suspension was used to inoculate DEF monolayers, obtained 
from 13-day old decapitated and eviscerated duck embryos by trypsinization (using 
0.25% trypsin).  DEF were incubated in complete LM medium containing 5% new born 
calf (NBC) serum and 50 µg/ml penicillin-streptomycin for 24 h. The inoculated DEF 
  
54 
cultures were then washed once with phosphate-buffered saline (PBS), replaced with 
fresh LM medium supplemented with 2% fetal calf serum, and incubated for 5–7 days. 
Infected DEFs were trypsinized using 0.25% trypsin and cocultivated with freshly plated 
DEFs. This procedure was repeated for a minimum of 3 passages. 
RNA Isolation 
Total RNA was extracted from brain tissue or infected DEF using the RNeasy 
Mini Kit (Qiagen). Tissue aliquots were 0.2 to 0.5 g pieces that were disrupted and 
homogenized in guanidine isothiocyanate-containing buffer using VWR
®
 Disposable 
Tissue Grinders (Cat. 47732-446 or 47747-366). To process about 10
6
 DEF, the growth 
medium was aspirated and the cells were washed one time with PBS. The PBS was then 
aspirated, and PBS containing 0.25% trypsin was added to flasks to detach the cells from 
the dish. The cells were pelleted by centrifuging at 300 X g for 5 min and were washed 
with PBS and pelleted again. Cells were then lysed in guanidine isothiocyanate-
containing buffer and the lysate was passed through a 20-gauge (0.9 mm) needle 
attached to a sterile plastic syringe at least 5 times–or until a homogeneous lysate was 
achieved. The samples were loaded onto the RNeasy mini column (Qiagen), washed and 
eluted as suggested by the manufacturor (Qiagen). 
The concentration of RNA was measured using a NanoDrop
®
 ND-1000 UV-Vis 
Spectrophotometer by applying 1.5 μl of sample. The RNA was either immediately used 
for cDNA synthesis or frozen at -80 °C for later use. 
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cDNA Synthesis 
The High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) was 
used to synthesize single-stranded cDNA from total RNA using random hexamer 
primers. Briefly the procedure was as follows:  A 2X Reverse Transcription Master Mix 
was prepared as recommended by manufacturer. To create a 1X mix, 10 μl of RNA 
sample, containing approximately 250 ng to 1 μg of RNA, was added to 10 μl of the 2X 
RT Master Mix. The samples were then incubated at 25 °C for 10 min, followed by 37 
°C for 120 min and 85 °C for 5 min.  The cDNA is then used immediately for PCR or 
stored frozen at -80 °C. 
Primer Design and PCR 
Forty-eight primers were designed to amplify and sequence different regions of 
ABV. The forward and reverse primers initially used were designed based on available 
Borna sequences in GenBank
®
 (Accession NO.: FJ169441.1, FJ169440.1, FJ620690.1 
and NC_001607) (3, 39). Table 8 lists the primers that were used to amplify and 
sequence the ABV genomes. Table 9 indicates the amplified regions and the primers 
used for sequencing. The PCR conditions used to generate ABV fragments were as 
follows: Initial denaturation, 94 °C for 2 minutes, followed by 30 or 40 cycles of 94 °C, 
30 s combined with the annealing at 50 to 55 °C (based on primer melting temperatures 
(Tm)) for 30 seconds and extension at 72 °C for 1 to 3 minutes (depending on fragment 
length), followed by a final extension of 10 minutes at 72 °C. The final PCR reactions 
contained: 1X of Platinum
® 
Taq DNA Polymerase Buffer (minus Mg, Invitrogen), 0.2 
mM of each dNTP, 1.5 mM MgCl2, 0.2 μM of each primer, 1 to 5μl of cDNA and 1.0 
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unit of Platinum
® 
Taq DNA Polymerase. The PCR products were analyzed by 
fractionation on 0.8 to 1% agarose gels containing 0.002% ethidium bromide and were 
visualized under UV light. 
Rapid Amplification of cDNA Ends 
In order to obtain the 5‟end of ABV genome, we performed rapid amplification 
of cDNA ends (RACE) using the Invitrogen
TM
 5´ RACE System, Version 2.0. In brief, a 
gene-specific primer, GSP-Borna 8150For  (CTT CAT GGT GAT CCT T), was used 
to synthesize the first strand of cDNA according to manufacturer‟s protocol. This cDNA 
was purified using the QIAquick PCR purification kit (Qiagen, Cat. 28104) and terminal 
transferase (TdT, Invitrogen) tailing with dCTP was performed as recommended by the 
manufacturer.  Tailed cDNA was then amplified by PCR with Platinum
®
 Taq DNA 
Polymerase (Invitrogen) using 5-μl volumes of the tailing reaction and the Abridged 
Anchor primer (5′-GGC CAC GCG TCG ACT AGT ACG GGI IGG GII GGG IIG-3′, 
Invitrogen) and the gene-specific primer, GSP3-Borna 8260For (GTG GTG TTC 
ATA TTG GAG GAC CAT CKG ACT CAT). The conditions for amplifying the 5‟ end 
included an initial denaturation at 94 °C for 3 minutes, thirty-seven cycles at 94 °C for 
30 sec, 55 °C for 30 sec, and 72 °C for 1 minute, followed by a final extension at 72 °C 
for 7 minutes.   
In order to generate the 3‟ end of the ABV genome, cDNA synthesized with 
random hexamers was linearly amplified using the gene specific primer, GSP1-Borna 
700Rev (GTC AGT AGT TAA TAA AGC AA PCR). Conditions for linear 
amplification of the 3‟end were as follows: an initial denaturation at 94 °C for 2 minutes, 
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forty cycles at 94 °C for 30 sec, 40 °C for 30 sec, and 72 °C for 1 min and 40 sec, 
followed by a final extension at 72 °C for 10 min. Linear amplified products were then 
gel purified and tailed as described above. Tailed products were then amplified by PCR 
with Platinum
® Taq DNA Polymerase (Invitrogen) using 5 μl volumes of the tailing 
reaction and the Abridged Anchor primer (5′-GGC CAC GCG TCG ACT AGT ACG 
GGI IGG GII GGG IIG-3′, Invitrogen) and gene-specific primer, GSP2-Borna 515Rev 
(GCG GAT GAG CCT ATG ACC ACT CCA AT). The conditions for amplifying the 3‟ 
end included an initial denaturation at 94 °C for 2 minutes, thirty-seven cycles at 94 °C 
for 30 sec, 55 °C for 30 sec, and 72 °C for 1 min, followed by a final extension at 72 °C 
for 7 min. 
PCR products of the 5‟- and 3‟-RACE reactions were visualized in 0.9% agarose 
gels containing 0.002% ethidium bromide. Products were cloned into the pCR
® 
2.1 
vector (Invitrogen) using the Invitrogen TA Cloning
® 
Kit (Cat. KNM2040-01) and then 
TOP10 cells were transformed according to the manufacturer‟s protocol (One Shot® 
Chemical Transformation Procedure; Invitrogen). The transformed cells were spread on 
LB plates containing 50 μg/ml kanamycin and incubated overnight at 37 °C.  The 
resulting colonies were PCR-screened to identify 5‟- and 3‟- RACE PCR products. The 
positive cells were then grown overnight at 37 °C in 3 ml of LB medium contacting 50 
μg/ml kanamycin. The 5 Prime FastPlasmid Mini Kit (Invitrogen, Cat. 2300010) was 
used for plasmid purification.   
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Sequence Analysis 
Some PCR products, including all of those generated by 5‟ and 3‟ RACE, were 
cloned into a TOPO-TA vector (Invitrogen) and individual plasmids were sequenced. 
Alternatively PCR products were purified using QIAquick PCR Purification Kit 
(Qiagen, Cat. 28104) (if only a single product was detected) or gel purified using 
QIAquick Gel Extraction Kit (Qiagen, Cat. 28704) (when multiple bands were 
obtained), according to the manufacturer‟s recommendations. The purified PCR products 
were used for direct sequencing using one of the primers used for the PCR. All DNA 
sequencing reactions were performed with the ABI BigDye Terminator Cycle 
Sequencing Kit (Applied Biosystems) and sequences were generated with an ABI 
PRISM 3100 Genetic Analyzer (Applied Biosystems). Sequences were assembled and 
aligned using Sequencher 4.8 (http://www.idmb.tamu.edu/gtl/sequencher.htm) and 
Geneious Pro 4.6.2 software (www.geneious.com). Available ABV genome sequences 
(FJ620690.1 and EU781967.1) were used to assist in contig assembly, however in all 
cases, overlapping PCR fragments were obtained and PCR primer sequences were 
removed from the data.  
Phylogeny 
The full-length nucleotide and deduced amino acid sequences of respective genes 
were used for phylogenetic analyses. Multiple sequence alignments were done by 
ClustalW and phylogenetic trees were constructed using the neighbor-joining method. 
  
Table 8 Primers used for sequencing the ABV genome.  
Sequence Name  Bases Sequence
a 
Tm °C 
Borna 5For 21 GCG GTA ACA ACC AAC CAG CAA 59 
Borna 1200For 25 GTA ACY GGA TTY GCA AAC TAA TGA A 54 
Borna 1700For 31 GAA TGA RAC TAT GAA RAT GAT GAT GGA GAA A 55 
Borna 3800Rev 25 CCC CAR GTY AKT GTA ACM ACT CKA A 57 
Borna 5400Rev 20 GGY CGR AAW GCR TTA CAC CA 57 
Borna 3310Rev 21 CGC TGA CCT GAR TTA ACA GTT 54 
Borna 2430For 19 GGG GGT TCT TTG GWA GTT A 52 
Borna 5190For 21 GAC TAT GAG YTC RAC BTC ACT 53 
Borna 7580Rev 21 CCT TAG GTC CGC AAG AGA AAA 55 
Borna 8640Rev 27 GCC TTC GAG TAA AAA TAA TAT GTA ATT 50 
Borna 6880Rev 25 GGC AGT ATT TGA CCC TAA GTA CAA A 55 
Borna 6100For 23 CCA AGT GTR TTT TTC CGY GGA AT 56 
Borna 8690Rev 24 GGT ATC CTT CCA TTA ATC GTG ATT 53 
Borna 8490Rev 24 CCA ATA ACT GTC CAC AAG TGC CTT 58 
Borna 6540For 20 GGA AGA TGT GGT GCT TGA GA 55 
Borna 7380For 19 GCC AGT ATC TGT GCC WGA A 55 
GSP1-Borna 700Rev 20 GTC AGT AGT TAA TAA AGC AA 45 
M25 
 
 
 
 
 
 
 
-Borna 1800For 
22 CCA ACT CTA CCC ACA GCT CCA A 59 
M25-Borna 4740Rev 21 CGA TCT GTT GCA TCC TGG TTT 56 
GSP1-CT15 Borna 705Rev 18 CCA CTA ATT TGA TCT GAT 43 
GSP1-M25Borna 695Rev 17 GGT AGT TAG TAA CGC AA 46 
Borna 1313Rev 19 GCT GTC TGC GGG TCG TCT T 60 
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Table 8, Continued 
 
 
 
 
   
Sequence Name  Bases Sequence
a 
Tm °C 
GSP3-Borna 8260For 33 GTG GTG TTC ATA TTG GAG GAC CAT CKG ACT CAT 63 
GSP2-Borna 515Rev 26 GCG GAT GAG CCT ATG ACC ACT CCA AT 62 
GSP-Borna 8150For 16 CTT CAT GGT GAT CCT T 45 
Abridged Anchor Primer  (AAP) 30 GGC CAC GCG TCG ACT AGT ACG GGG GGG GGG 74 
Borna 3000For 19 GGG ARG ACT GYG AAA TTT T 50 
Borna 3700 (2)For 20 CGG MMR GTG GTC GGA ATA AA 56 
Borna 3300Rev 22 GCC ARA YAA CMC CDA YYC CAT T 57 
Borna 2710Rev 20 CTG TGC TGC ART CTG CAA AA 55 
M25-Borna 7790Rev 22 GGG ATA TCA AAT CAC GCC TAT T 53 
M25-Borna 6570For 21 GCA AGC CGT TAT AGA CCA TAT 52 
M24-Borna 315For 20 GCC AGT CAA GCA AGG AGA AC 56 
M24-Borna 444Rev 20 CGG ATG AGC CTA TGA CCA CT 56 
M25-Borna 2710For 24 GCA CAG TCA ATG AGA AGG ATC TAT 54 
M25-Borna 3950Rev 23 CAG CTC GGA TTA GTA CAC CAA TT 55 
M25-Borna 6050For 21 GGT CCG TCA TTA GGT GGT CTT 57 
M25-Borna 8460Rev 19 GGC TGT GAA TGG ACC GAT A 54 
Borna 8550For 19 SCA TGT GGA GGA RTT TGA T 51 
M25-Borna 3040For 19 GGT TCG TTT GGG AAT GGT A 52 
M25-Borna 3540Rev 20 CCC GTA TCA GTT GAG GTT AA 52 
 
a
All primers were purchased from Integrated DNA Technologies and were purified by standard desalting.  In this table, standard IUB 
symbols are used to designate mixed bases (9) 
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Table 9 Regions of ABV amplified by PCR and the primers used for sequencing 
 
Region Primer for PCR and sequencing   Internal primers for sequencing 
ABV- N region Borna: 5For & 1313Rev         
ABV-X, P, and M regions Borna 1200For & Borna 1930Rev    
ABV-G region Borna: 1700For & 3800Rev  Borna 2430For Borna 3310Rev 
ABV-L1 region Borna 3700Fo. & Borna 6300Rev  Borna 5190For  
ABV-L2 regions Borna 6100For. & Borna 7580Rev  Borna 6880Rev  
ABV-L3 region Borna 7380 For. & Borna 8490Rev    
ABV-O1-G1 region Borna 1700For. & Borna 3310Rev   
M25-G1 region M25-Borna 1800For. & Borna 3800Rev   
M25-G2 region M25-Borna 2710For & Borna 3950Rev   
M25-L1 region Borna 3700(2)For &M25- Borna 4740Rev   
M25-L2 region M25-Borna 6050For & Borna 8460Rev     
6
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Results 
Organization of ABV Genomes 
The genome organization of the bornaviruses is unique among the 
Mononegavirales. Some genes, for example M and G, are overlapping and discrete 
transcription start and stop sites do not occur between each open reading frame. The 
ABV isolates from this study showed the same overall genome organization as 
previously characterized ABVs (39, 59) with six ORFs encoding homologs of the BDV 
N, X, P, M, G, and L genes (Fig 8). The relative position of each gene and the degree of 
gene overlap was also well conserved. The most notable difference in the organization of 
the ABV and BDV genomes was the deletion of an approximately 20 nt sequence 
between the N and X genes that was previously noted for ABV (39, 59).   
Texas Isolates Belong to Three Different ABV Genotypes 
Phylogenetic trees were generated to determine the genotypes represented by the 
Texas ABV isolates. Initially, partial N sequences (397 nt) were used to generate a tree 
containing 12 ABV strains with previously designated genotypes (39) and the Texas 
isolates (Fig. 9). Seven of the Texas ABV genomes (NM-M10, NM-M14, NM-M15, 
NM-M20, NM-AG5, NM-01 and NM-06) formed two clusters in a branch of the tree 
containing other genotype 4 ABVs (ABV4). The Texas isolates were more closely 
related to one another than to the other ABV4s.  One Texas ABV, NM-M25, was 
genotype 1 and one, NM-CT15, was genotype 2 (Fig. 9).  
  
Fig. 8 ABV genome organization. Alignments of entire genomes showing predicted open reading frames for the Texas ABV isolates. 
The overall gene organization of the Texas ABV isolates was identical to BDV and previously characterized ABVs (65). 
6
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Fig. 9  Neighbor joining tree for a 379 nt region N. NC-001607 (BDV) was used as the out-
group. Isolates designated ABV1,  ABV2, ABV3, ABV4, and ABV5 were previously assigned 
to these groups (39, 65). Texas isolates are: M25, M24, O6, M15, AG5, M10, M20 and M14. 
Node labels show consensus support.  
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Additional phylogenies were generated using complete X, P, M, G and L gene 
sequences (Fig. 10). Sequences from two complete ABV2 genomes (Accession Nos. 
FJ620690 and EU781967.1), were included in the analyses. At the time of the analysis 
complete genome sequences of other genotypes were not available. In each tree, NM-
CT15 grouped closely with EU781967.1, an ABV2 isolated from crop tissue from a Sun 
Parakeet (Aratinga solstitialis) in the United States (39).  NM-M25, designated an 
ABV1 based on N sequences, always appeared on its own branch, The Texas ABV4 
isolates always split into two clusters, one containing NM-01 and NM-06 and the other 
containing the isolates NM-M14, NM-M15, NM-M20 and NM-AG5.  
Identification of Putative Regulatory Sequences 
Analysis of BDV transcripts has identified 3 transcription initiation sites (TIS) 
and 4 major transcription termination (TER) sites (61). At similar locations in the ABV 
genome we identified putative TIS (Fig. 11a-c).  We predict that ABV TIS1 and TIS3 
overlap the confirmed BDV TIS but that the transcript initiation sites are 2 to 3 nt closer 
to the start codon of the downstream ORFs. The region of the ABV and BDV genomes 
that is most divergent falls between the end of the N gene and the beginning of the X 
gene. The ABV genome lacks a 22 nt stretch present in BDV (Fig. 11a). We predict that 
the ABV TIS2 site is downstream of the mapped BDV site, placing the transcription 
initiation site 22 nt closer to the start codon of the X gene.  Four transcription 
termination sites (T1-T4) have been mapped for BDV (61). The TER are U-rich sites in 
the BDV genome that serve as polyadenylation sites of viral transcripts.  The ABV 
genomes are identical to BDV at all four termination sites (Fig. 11b, d, e). 
  
Fig. 10 Neighbor joining trees generated using the complete nt sequence of N, X, P, M and G and L genes. NC_001607 (BDV) was used 
as the out-group. FJ620690 and EU81967.1 are genotype 2 ABVs whose complete sequences are available in Genbank. The Texas isolates 
all cluster as shown for the partial N gene sequences. Only ABV genotypes 1, 2, and 4 are included in this figure as complete genome 
sequences are not available for genotypes 3 and 5. 
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Fig. 10, Continued 
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Fig. 11 Potential transcription initiation (TIS) and transcription termination sites (TER) for ABV. a, b, c The postion putative TIS in 
ABV. The region of the ABV and BDV genomes that is most divergent falls between the end of the N gene and the beginning of the X 
gene. The ABV genome lacks a 22 nt stretch present in BDV (a). b, d, e  The ABV genomes are identical to BDV at all four termination 
sites. 
A B 
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Fig. 11, Continued 
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Pairwise Comparisons of ABV and BDV Sequences  
Pairwise comparisons of ABV and BDV sequences revealed that although the 
overall phylogenies agreed for each protein, the degree of nucleotide and amino acid 
sequence variation varied among the genes and their predicted proteins, as shown in 
Table 10. Overall, for comparisons of BDV to ABV genotypes, the percent amino acid 
identities were, from highest to lowest: M (~84%), N (75-77%), L (66-68%), G (65-
67%), P (59-63%) and X (41-50%). At the nucleotide sequence level, identity of BDV to 
ABV genotypes was: M (71-75%), X (63-71%), N (63-68%), G (64-66%), P (63-65%) 
and L (61-63%). Pairwise sequence comparisons among the complete ABV genomes 
showed that all of the ABV isolates were more closely related to each other than to 
BDV, as expected. The percent amino acid identities were, from highest to lowest: M 
(95-97%), N (93-100), P (93-100%), L (91-100%), G (88-100%) and X (84-100%). 
Percent nucleotide identities among the ABVs were: X (88-100%), M (85-100%), P (83-
100%), N (81-99%), G (80-100%) and L (79-100%). An unusual result in both sets of 
comparisons was the X protein, whose observed nucleotide sequence identity was 
greater than the predicted amino acid sequence identity.  This occurred because X 
protein is short (87-88 aa) and rich in leucine and arginine. 
 
  
Table 10 Summary of nucleotide and amino acid identities from comparisons of ABV and BDV genes  
 Percent Identity 
 
 N 
(375-374 
aa)
a
 
 
X 
(88-87 aa) 
P 
(202 aa) 
M 
(142aa) 
G 
(500-503 
aa) 
L
b
  
(1702-1706 
aa) 
Isolates compared: aa* nt** aa nt aa nt aa nt aa nt aa nt 
NM-ABV4
c
 98-100 94-99 
93-
100 
96-
100 
98-
100 
95-
100 
†97-
100 
95-
100 
97-
100 
94-
100 
98-100 95-99 
ABV2
d
 99-100 95-98 95-98 98-99 98-99 96-99 98 97-98 97-98 97-98 98-99 96-98 
NM-ABV4
c
  v. 
ABV2
d
 
93-95 81-82 74-79 87-88 93-95 83-85 96-97 86-87 88-90 80-82 89-90 79 
NM-ABV4
c
  v. 
ABV1
e
 
94-95 81-82 84 90-91 94-95 84 95-96 85-86 88- 90 81 90-91 79-80 
ABV2
d
  v. ABV1
e
 97-98 81-82 84-87 91-92 94-95 85-86 97-99 89 91-92 82-83 91 80 
BDV
 f
 98 84 80 88 96 86 97 88 93 82 92 78 
BDV v. NM-ABV4
c
 75-77 64-68 45-50 67-71 60-63 65-66 84-85 75 65-66 65-66 67-68 61-63 
BDV v. NM-CT15 75-76 63-67 41-47 63-68 59-62 63-66 83 72-74 66-67 65-66 67-68 61-63 
BDV v. NM-M25 76-77 64-68 47 70 60-62 64-65 83 71-74 65 64-65 66-67 61-62 
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Table 10, Continued 
 
a
For each protein, the range of amino acid lengths are shown. 
b
Data was calculated for only for the L gene second exon. 
c
Comparisons of Texas isolates NM -M10, -M14, -M15, -M20, -AG5, -01 and -06. 
d
Comparisons of Texas isolates NM-CT15, FJ620690 and EU781967.1.  
e
ABV1 is Texas isolate NM-M25. 
f
BDV sequences compared are AJ311524 and NC001706.1. 
* Percent amino acid sequence identities are shown. These were calculated using CLUSTAL W (1.81) multiple sequence 
alignments with the BLOSUM matrix. In comparisons of groups of isolates, the values are presented as a range from the most 
divergent pair (lowest percent identity) in the group to the most conserved pair.  
** Percent nucleotide sequence identities were calculated using CLUSTAL W multiple sequence alignments with the IUB 
matrix. In comparisons of groups of isolates, the values are presented as a range from the most divergent pair (lowest percent 
identity) in the group to the most conserved pair.  
†
Values for NM-AG5 are not included due to an unresolved frame-shift in the M protein. 
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Characterization of Predicted ABV Proteins 
  The ABV gene order is identical to BDV.  Nucleotide and amino acid sequence 
similarities strongly suggest that predicted ABV proteins are homologous to those in 
BDV.  A brief description of each protein follows.  
N Protein 
The BDV N protein is 371 amino acids (aa) and is expressed from an S1 mRNA 
transcript. The predicted ABV N proteins for the Texas isolates were 374 amino acids 
and shared 270 (~72%) identical sites with BDV. Among the ABVs the N proteins 
shared 344 identical sites. Two ABV N‟s from Genbank (FJ620690 and EU781967.1) 
have identical N protein sequences; among the Texas isolates NM-CT15 was the most 
closely related to those isolates, sharing 99% identical sites. BDV N has a nuclear 
localization signal (NLS) near its N-terminus and the 371 aa N product (p40) has a 
nuclear localization. A second BDV N protein, p38, initiates at a second methionine 
codon 14 aa downstream and thus lacks the NLS. The ABV N proteins of the Texas 
isolates shared 9 identical sites at their amino termini, predicting a motif that could 
function as proline-containing NLS. The ABVs also shared a methionine, at position 16, 
that could serve as a second translation start site to produce a shorter N protein.  
X Protein 
The BDV X protein is 88 amino acids. The BDV X gene starts upstream of the P 
gene, but overlaps it. BDV X and P are likely translated from transcripts that initiate at 
the S2 transcription initiation site. A comparison of the Texas ABVs and BDV showed 
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that overall the X proteins shared only 34 identical sites (39%). Among the Texas ABVs, 
where X is predicted to be 87 aa, the number of identical sites was 61 aa (~69%). Four of 
the Texas ABV isolates (NM-M14, NM-M15, NM-M20 and NM-AG5) had identical X 
proteins. The two ABV2 isolates (FJ620690 and EU781967.1), have identical N 
proteins, but have X proteins that differ by 4%. The NM-CT15 X protein was most 
closely related to EU781967.1 (86 identical sites) and shared 84 identical sites with 
FJ620690.  NM-M14, NM-M15, NM-M20 and NM-AG5 also had identical X proteins.  
The NM-06 X protein was most closely related to the NM-01 X protein. 
P Protein 
The BDV P protein is 203 aa. The ABV P proteins were also predicted to be 203 
aa and overall, they shared 116 (57%) identical positions with BDV P. Among the 
ABVs, the NM-AG-5, NM-M14 and NM-M15 P proteins were identical. The NM-06 
and NM-01 P proteins were also identical. NM-CT-15 shared 202 of 203 sites with 
EU781967.1 and 199 sites with FJ620690, but only 190 sites with the AG-5 group of 
ABVs.  NM-M25 showed 61% identity with BDV, 93.6% identity with NM-CT15, 
90.5% identity with the AG-5 group and 90.6% identity with the NM-01/06 isolates.  
G Protein  
The virion surface glycoprotein (G) is responsible for BDV attachment and 
fusion (22) and encodes a highly glycosylated 504 aa precursor protein (gp94). Furin 
cleavage of BDV G yields GP-1 and GP-2 that correspond to the N- and C-terminal 
regions of gp94. Like the BDV, the ABV G open reading frame predicted a highly 
  
75 
glycosylated 504 aa protein with a furin cleavage site. The furin cleavage site was 
conserved between ABV and BDV and among different genotypes of ABV (Fig. 12). 
The ABV G proteins had more predicted N-linked glycosylated sites (NXS/T) than BDV 
(Fig. 13). The BDV G aa sequence ranges from 65-66% identical to the ABV Gs.  
Among the ABV G proteins, NM-M25 was the most different sharing 88% aa identity 
with NM-06 and the most (93%) with NM-CT15. 
L Protein  
The BDV L protein is 1711 aa in length. It is translated from a spliced mRNA 
such that the first 5 aa of L are encoded from a region that overlaps the G (15). The ABV 
L protein sequences were translated in silico using the assumption that a similar splicing 
event generates the ABV L mRNAs, as nucleotide sequence comparisons show 
conservation of consensus intron/exon boundaries in the ABV genomes.  The ABV L 
proteins range in size from 1710 to 1713 aa. A comparison of BDV to ten ABV L 
proteins predicts 63.7% identical sites. BDV L is ~60% identical to ABV L at the aa 
sequence level.  All of the ABV isolates were more closely related to one another than to 
the BDV L protein. Among the ABV sequences, NM-01, NM-06, NM-M20, NM-AG5, 
NM-M14 and NM-M15 formed a cluster and NM-CT15 grouped with other ABV2s 
(FJ620690 and EU781967.1). 
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Fig. 12 Conserved furin cleavage sites in BDV (1.NC_0016…) and ABV. The cleavage site is 
shown by yellow arrow in this figure. 
  
Fig. 13  G protein showing the locations of predicted N-linked glycosylation sites. The predicted N-linked glycosylation sites (NXS/T) are 
indicated by purple arrows.  
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Discussion 
We identified ABV genotypes 1, 2, and 4 in parrots and cockatiels originating 
from the United States.  ABV4 was the most common genotype. The ABV-infected 
birds showed either typical clinical signs of PDD or were healthy (or apparently 
healthy). All the isolates were successfully recovered in DEF but it is important to note 
that the sequences reported herein were obtained from RNA purified directly from brain 
tissues. N sequences were also recovered from cultured DEF and these were essentially 
identical to those from the brain tissue (data not shown).  
Comparing the viral genome structures, we confirmed that ABV genome 
organization is highly similar to BDV genome organization, with the same gene order as 
reported previously (34, 39, 59). The locations of transcription initiation and 
transcription termination sites were also conserved although the positions of the TIS 
were shifted closer to the start sites of the N, X and M ORFs. The most obvious 
difference was the location of TIS2, located upstream of the X gene.  In all of the ABVs 
this region was approximately 20 nt shorter than in BDV. This region of BDV contains a 
sequence important for regulating the frequency by which the polymerase terminates 
transcription after the N gene (55), thus is absence from ABV isolates suggests a 
different mechanism of regulating gene expression. 
Comparisons of predicted proteins reveal some motifs that are well conserved 
between ABV and BDV. Conserved motifs in the G protein included the furin cleavage 
site and most of potential N-linked glycosylation sites.  However, there were additional 
predicted potential N-linked glycosylation sites in the ABV G proteins, suggesting that 
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in ABV, G may be even more highly glycosylated than in BDV. Alteration of a 
glycosylation site can have dramatic consequences for a virus as it may impact protein 
folding or cause conformational changes (73). Although increases in glycosylation can 
sterically cover epitopes, the loss of a glycosylation site could result in tighter packing of 
the amino acid backbone. In regions containing neutralization epitopes this could reduce 
accessibility and also facilitate immune escape (72). Moreover, it has been shown that 
alteration in patterns of glycosylation sites in human immunodeficiency virus (HIV) and 
hepatitis C virus can be a factor in escape from T cell responses (2, 64). It has been 
shown in HIV and influenza virus that small changes in glycoproteins can influence 
receptor binding and phenotypic properties of viruses (37, 46). Therefore the differences 
in the glycoproteins of ABV and BDV may be the reason for difference in the cell 
tropism of two viruses. 
The M protein is the most highly conserved protein among the ABVs and BDV 
overall. Since M is a structural protein that assembles as homotetramers, (44) this may 
constrain sequence variability of M.   
The X proteins showed the least similarity between BDV and ABV. X is a 
regulatory protein which may play a role in negative regulation of BDV polymerase 
activity (54). Moreover, it has been recently shown that X represents the first 
mitochondrion-localized protein of an RNA virus, and that it inhibits apoptosis in 
cultured cells and infected animals (53). The role(s) or function(s) of the ABV X protein 
are not yet known, but amino acid sequence variation in this region is likely to have an 
impact on virus replication.  
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While the overall genome organization for the Bornaviridae was quite conserved, 
our ABV isolates showed much greater variability than observed among BDV strains 
from mammals. It is possible that the currently known BDV strains do not reflect the 
complete genetic repertoire of this virus and currently known BDV strains might only 
represent a small fraction of virus variants which are able to cross the between natural 
hosts of BDV and horse or sheep (65). 
This is the first report of complete genome sequences for ABV genotypes 4 and 
1. We failed to find any correlation between ABV genotypes and the bird species from 
which they were isolated. We isolated an ABV2 from a healthy cockatiel, while this 
genotype previously was isolated by others from macaws with PDD (39, 59). We 
isolated ABV4 from different species of birds such as macaws, African gray parrots and 
healthy cockatiels. Thus different genotypes of ABV appear to be able to infect the same 
species of birds. 
Hopefully, the data we presented here will provide a better understanding of 
structure of ABV. The sequence data are also critical for future studies, such as 
constructing a reverse genetic system as well as for vaccine development. There are also 
many questions that remain to be addressed, such as the importance of the differences 
between ABV and BDV genomes, or even among different ABV strains and the effects 
these differences have on virus transmission, replication and disease.  
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  CHAPTER IV 
AVIAN BORNAVIRUS, GENOTYPE 2 CAUSES PROVENTRICULAR 
DILATATION DISEASE IN COCKATIELS (NYMPHICUS 
HOLLANDICUS) 
Introduction 
ABV is the cause of PDD in psittacines and some passerines and waterfowl (21, 
26, 35, 49) The clinical presentations of PDD vary and may be predominately 
neurological (weakness, ataxia, proprioceptive deficits, seizures, blindness), 
gastrointestinal (weight loss, passage of undigested food, regurgitation, delayed crop 
emptying), or a combination thereof (66). The gastrointestinal signs, especially 
proventricular dilatation, are secondary to damage to the enteric nervous system. Typical 
PDD is characterized by the presence of a lymphoplasmacytic inflammation in 
peripheral, central and autonomic nervous tissues (1).   
Epidemiological studies have shown however that ABV is carried by many 
apparently healthy birds (49). This appears to be especially true of cockatiels where a 
high percentage of birds may be shedding the virus in their feces (26). Although not 
unexpected in a RNA virus, ABV is genetically diverse with 7 distinct genotypes 
identified to date.  All 7 genotypes have been isolated from psittacine cases of PDD
 
but 
is of interest to note however that both in Europe and North America, ABV4 is by far the 
predominant genotype isolated (65). This may be due either to a true predominance of 
genotype 4 among birds, or alternatively, because ABV4 is more virulent than other 
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genotypes and is thus more likely to be encountered when investigating deaths due to 
PDD.  
  No formal investigations into the relative virulence of the different genotypes of 
ABV have yet been undertaken. Given that all genotypes identified to date have been 
identified in diseased birds, it is likely that all are capable of causing disease. Recently 
however, we isolated ABV genotype 2 (ABV2) from a cockatiel that, while not healthy, 
did not appear to be suffering from PDD, and indeed appeared to be a carrier of the 
virus. Because the infected cockatiel was relatively healthy and did not have gross 
lesions suggestive of PDD, it was hypothesized that this particular strain of ABV2 was 
either avirulent or of low virulence. In order to test this hypothesis the isolate was 
cultured and used to challenge two healthy cockatiels.  
Materials and Methods 
Experimental Infections 
Experimental infections were carried out under Animal Use Protocol #2009-
033B approved by the Texas A&M University Institutional Animal Care and Use 
Committee. Two (No. 1 and No. 13) adult male and female Cockatiels (Nymphicus 
hollandicus) shown to be intermittent shedders of ABV4 by fecal RT-PCR, but 
otherwise in good health, were placed in isolation and inoculated by intramuscular 
injection with infected DEFs (cell culture passage 6) containing 8x10
4
 focus forming 
units (FFU) of an ABV2 isolate from cockatiel 15 (this isolate was sequenced and was 
designated NM-CT15). Additionally 4x10
5
 FFU were administered by oral gavage.  A 
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third cockatiel (No. 10) was retained as a negative control bird. During inoculation, 
1.4x10
5
 FFU were retained for culture to assure that birds had received viable virus. The 
birds were housed in flight cages and provided food and water ad libitum. Control birds 
were housed in a separate aviary.  
Challenge Virus 
 ABV2 was cultured for 6 passages in DEF monolayers as described previously 
(26). A piece of frozen CT15 brain was homogenized in 4 ml of LM (containing 5% 
NBC serum, 1μg/ml Fungizone (antimycotic), and 50 µg/ml penicillin-streptomycin 
using a 5 CC syringe and 20 GA gauge needle. The homogenates were used to inoculate 
two confluent T12.5 flasks of DEF.  After overnight incubation at 37 °C with 5% CO2, 
the supernatants were replaced with fresh 2% LM and incubated for 5 to 7 days. The 
inoculated cells were then harvested using 0.25% trypsin and transferred to a larger 
flask. The cells were passaged 6 times, collected and frozen at -80ºC using frozen media 
(LM+10% DMSO, 50% NBC serum). Virus was titered by plating serial dilutions of 
infected DEF onto uninfected monolayers in 6 well-plate and incubating for 5 to 7 days. 
The infected cell foci were detected by immunohistochemistry using serum from bird 
M10 (a PDD positive bird) and secondary antibody (goat anti-macaw conjugated with 
HRP) and developed using Sigma Fast DAB. Foci were counted using an optical 
microscope.  
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Sample Testing 
Fecal samples were taken at weekly intervals from challenged and control birds 
for PCR analysis. Briefly, fecal drops were collected with a clean swab and suspended in 
about 500–750 µl of sterile phosphate buffered saline (PBS). Vials containing fecal 
material were transported on ice and either immediately processed for RNA isolation or 
frozen at -80 ºC until RNA processing. RNA was purified from the supernatants using 
QIAamp Viral RNA Mini kit (Qiagen), according to the manufacturer‟s 
recommendations. First strand cDNA was generated using the Applied Biosystems
®
 
High Capacity cDNA Reverse Transcription Kit (Applied Biosystems), with 1μg RNA 
and random primers. cDNA was amplified using primer sets: Forward (5' 
CAGACAGCACGTCGAGTGAGA 3') and Reverse (5' GGCTCTTGGTCT 
GAGATCATGGAA 3‟). The PCR conditions were as follows: Initial denaturation, 94 
°C for 3 min, followed by 35 cycles of 94 °C, 30 sec, 54 °C, 30 sec and 72 °C, 20 sec 
followed by a final extension of 5 min at 72 °C. Samples were electrophoresed in 0.9% 
agarose gels containing 0.002% ethidium bromide and were visualized under UV light.  
Pathology  
Immediately upon euthanasia, complete necropsies were performed on all birds. 
Tissue samples from brain, spinal cord, peripheral nerves, eyes, lungs, heart, liver, 
pancreas, spleen, kidneys, ovary, oviduct, adrenal gland, skeletal muscles, esophagus, 
crop, proventriculus, ventriculus, intestine and cloacal were placed in 10% buffered 
formalin, embedded in paraffin, sectioned at four micrometers, stained with hematoxylin 
and eosin (H & E), and examined by bright field microscopy.  
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Detection of ABV by PCR  
During necropsy of infected and control cockatiels, small portions of brain, 
lungs, heart, liver, pancreas, spleen, kidneys, and adrenal glands, were snap frozen at -80 
°C. Total RNA was isolated from these frozen tissues or from passaged DEF using 
Qiagen RNeasy Mini kit (Qiagen,Valencia, CA). First strand cDNA was generated using 
the Applied Biosystems
®
 High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems), with 1μg RNA and random primers. For tissue samples, PCR of a region of 
the ABV N-gene was performed using 1-2 μl cDNA and forward (5F: 
5‟GCGGTAACAACCAACCAGCAA3‟) and reverse (1212R: 
5‟GTTCATTAGTTTGCRAATCCRGTTA3‟) primers designed based on previously 
reported ABV N-protein gene sequences (68). Amplification conditions were as follows: 
1 cycle at 94 °C for 2 min; 35 cycles at 94 °C for 30 sec, 50 °C for 30 sec, and 72 °C for 
80 sec; final extension at 72 °C for 7 minutes. 
Genotyping 
PCR products were cloned into TOPO-TA vectors (Invitrogen, Carlsbad CA) and 
individual clones were sequenced after transformation into E. coli. Alternatively, PCR 
products were sequenced directly. DNA sequencing reactions were performed using the 
ABI BigDye Terminator Cycle Sequencing Kit, and sequences were generated with an 
ABI PRISM
®
 3100 Genetic Analyzer (Applied Biosystems). Sequences were assembled 
and aligned using Sequencher 4.8 (http://www.idmb.tamu.edu/gtl/sequencher.htm) and 
Geneious Pro 4.6.2 software (www.geneious.com).  
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Results 
In order to investigate the virulence of CT15 a genotype 2 ABV, a small 
challenge study was conducted.  This ABV2 isolate was recovered from the brain of an 
infected cockatiel (CT15) that had presented with lesions not suggestive of PDD (data 
not shown).  After experimental infection, CT15 infected and control birds were checked 
daily. There were no obvious immediate responses to inoculation. No PCR-positive fecal 
samples were detected from these birds at any time.  However on day 33 one bird (No. 
13) was observed to be depressed. Over the next few days the bird lost weight, became 
weak, and on day 36 was observed clinging to the cage wall by its beak. This bird was 
euthanized for ethical reasons.  On necropsy, the bird was thin with a moderate loss of 
pectoral muscle mass. Its gastrointestinal tract was empty. The liver was slightly 
enlarged and the proventriculus slightly dilated.  The second challenged bird  (No. 1) 
remained in apparent good health until day 41 when it also was observed to be 
depressed. It gradually became inactive and it was clearly losing weight. This bird was 
euthanized on day 45.  It too had moderate pectoral muscle wastage. It had a slightly 
enlarged liver and spleen, an empty and somewhat enlarged small intestine, and a 
slightly dilated proventriculus. No other gross lesions were observed in either bird.  
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Histopathological examination of Bird No. 13 identified typical lesions of PDD 
with a moderate multifocal encephalitis and mild myocarditis (Fig. 14), adrenalitis and 
intestinal ganglioneuritis.  The brain lesions were more significant than in other organs. 
Tissues of the second cockatiel, bird No. 1 also showed lesions of PDD. It had mild 
encephalomyelitis, adrenalitis, and intestinal ganglioneuritis. It also had very severe 
ganglioneuritis of the epicardial ganglia (Fig. 14).  
In order to study the sites of viral replication in infected birds, PCR was 
performed using primer mix 5 or N (Table 2) on pieces of forebrain, spinal cord, heart, 
lung, spleen, kidney, crop, proventriculus, ventriculus and adrenal gland. In infected-
cockatiel No. 1 (CTI1) the virus was detected in brain and CNS, as well as heart, lung, 
liver, spleen, kidney, crop, proventriculus, and ventriculus (Fig. 15). In infected-
cockatiel No. 13 (CTI13), no virus sequence was found in the forebrain, however, the 
virus was detected in spinal cord, spleen, kidney, proventriculus and adrenal gland. Only 
the liver was negative for both infected birds. There was no virus detected in the 
uninfected cockatiel (CT10).  
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Fig. 14  Histological examination of ABV2 infected cockatiels. a Bird No. 13 showing mild 
infiltration of lymphocytes and a few plasma cells in and around Purkinje cells of the 
myocardium. b Bird No. 1 showing severe lymphoplasmacytic infiltration in the epicardial 
ganglia of the heart.  (We thank and acknowledge Dr. H.L. Shivaprasad for performing 
microscopic examination of tissues from ABV2 infected cockatiels and for providing these 
figures.) 
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Fig. 15 ABV in tissues of infected (CTI) or uninfected (CT) cockatiels. a Using primer mix N, a single band was observed in spinal cord  
(SC) of CTI1 and CTI13 and also in forebrain (FB) of CTI1. The lower band is a non-specific primer-dimer product. b Using primer mix 
5, ABV was detected in kidney (K), crop (C), and proventriculus (PV) of both infected cockatiels. The virus also detected in spleen (Sp.) 
and adrenal gland (AG) of CTI13 as well as heart (H), lung (Lu) and ventriculus (V) of CTI1. Virus was not detected in liver (L). No 
spsecific PCR products were seen in any tissues from the infectd control bird, CT10.  C. Loading control (β-actin). 
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Fig. 15, continued 
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Discussion 
 
We isolated a genotype 2 ABV from a cockatiel (CT15) with no evidence of 
PDD. The cockatiel, from which the isolate originated was euthanized because of a 
lipoma on its wing and it was not believed to be a clinical case of PDD. Previously, we 
had demonstrated that an ABV isolate of genotype 4 (M24) causes typical PDD in 
Patagonian conures (26) and cockatiels but that isolate was recovered from a bird with 
frank signs of PDD. We hypothesized that the ABV2 isolate, from a bird without clinical 
PDD, might be avirulent.  Identification of a non-pathogenic strain of ABV would be 
helpful by providing a potential starting point for the development of a vaccine. 
However, the deaths of two CT15-challenged birds, at days 35 and 44, indicated that 
ABV2 is fully virulent. The onset of disease was more rapid (44 days compared to 64 to 
111 days) than previously observed in experimental challenges with ABV4 isolates (21, 
49).  
It is interesting to compare the lesions induced in challenged cockatiels given 
similar doses of ABV4 and ABV2 in our laboratory. The two cockatiels challenged with 
ABV4 M24 died in about 100 days and had unusually florid and severe lesions involving 
primarily the gastrointestinal tract (49). In contrast, following ABV2 challenge the 
lesions were relatively mild, although sufficiently intense as to cause severe clinical 
disease. The observed differences in survival and lesions may be due to the involvement 
of the immune response.  As the CT15-challenged birds died at 35-44 days post-
challenge, perhaps there was not sufficient time for development of the severe 
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inflammatory lesions seen in the M24-challenged birds at 95-111 days post-challenge. 
That would imply that the inflammatory responses pre se do not drive disease 
development.  In fact the prolonged survival of the M24-challenged birds may well be a 
reflection of prior immunity, as this specific group of cockatiels was shown to be 
naturally infected with ABV4 a year prior to this study despite being apparently healthy 
(21).  
In several prior challenge studies we have employed multiple control birds that 
received uninfected DEFs. Experience with such birds indicated that no lesions or 
disease developed as a result of receiving these cells, thus additional DEF control birds 
were not sacrificed for this study. In summary, although this was a small pilot study, 
designed to obtain a preliminary assessment of the virulence of the ABV2 isolate CT15, 
it is clear that at the dose administered, this virus is fully virulent. Additional studies 
using alternative methods of virus delivery and/or doses that more closely reflect natural 
infection may demonstrate differences in the pathogenicity of ABV genotypes or 
isolates. 
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CHAPTER V 
CONCLUSIONS 
Using PCR, we were able to identify ABV in brain tissue from most suspected 
PDD cases. However PCR was less useful in detecting ABV infection among birds 
suspected of being clinically healthy carriers. For example, PCR failed to detect ABV 
shedding in 33% of ABV seropositive birds housed in the Schubot aviary. The failure of 
PCR in identifying ABV in those samples can be attributed to factors such as sample 
collection and handling, the frequency and levels of virus shedding and sequence 
divergence. Virus shedding was not limited to fecal samples and virus could be detected 
from other body sites such as nares, the choana, and the feathers.  However sampling 
these sites requires training of both the birds and handlers so the frequency of virus 
shedding from these sites was not determined in this study,  We can conclude that PCR 
testing of fecal samples alone is inadequate for ABV diagnosis or surveillance in 
individual birds. However, as the technique is sensitive, non-invasive, inexpensive, rapid 
and generally easy to perform, PCR screening is a good method for ABV detection 
amongst flocks, where a positive result is a strong indicator of the presence of the virus 
among members of the flock.  
In a study where the results of PCR and serology were compared, it was clear 
that neither assay alone is ideal because the results were discordant. Among 18 PCR 
positive birds, 12 (66%) were seronegative.  Serology did detect ABV infection in 3 of 
10 (30%) PCR negative birds.  The lack of a single clear diagnostic test for ABV 
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infection is unfortunate as aviculturists and pet owners fear the disease and would like to 
eliminate infected birds from their flocks, particularly as the birds in question are often 
threatened or endangered species.  Much more research is needed to determine the best 
methods for detecting healthy carriers as well as for protecting non-infected birds. 
The studies described herein also clearly demonstrate that multiple ABV 
genotypes can be found in psittacines. We identified ABV genotypes 1, 2, and 4 in 
parrots and cockatiels originating from the United States.  ABV4 was the most common 
genotype. The ABV-infected birds showed either typical clinical signs of PDD or were 
healthy (or apparently healthy).  
Comparing the viral genome structures, we confirmed that ABV genome 
organization is highly similar to BDV genome organization, The locations of 
transcription initiation and transcription termination sites were also conserved although 
the positions of the TIS were shifted closer to the start sites of the N, X and M ORFs. 
The most obvious difference was the location of TIS2, located upstream of the X gene.  
Comparisons of predicted proteins reveal some motifs that are well conserved between 
ABV and BDV. Conserved motifs in the G protein included the furin cleavage site and 
the majority of potential N-linked glycosylation sites.  However, there were additional 
predicted potential N-linked glycosylation sites in the ABV G proteins, suggesting that 
in ABV, G may be even more highly glycosylated than in BDV. The M protein is the 
most highly conserved protein among the ABVs and BDV overall. The X proteins shows 
the least similarity between BDV and ABV. 
While the overall genome organization for the Bornaviridae was quite conserved, 
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our ABV isolates showed much greater variability than observed among BDV strains 
from mammals. We failed to find any correlation between ABV genotypes and the bird 
species from which they were isolated. We isolated ABV4 from different species of 
birds such as macaws, African gray parrots and healthy cockatiels. Thus different 
genotypes of ABV appear to be able to infect the same species of birds. 
Finally, we conclude that ABV recovered from a healthy carrier can show the 
same virulence, in experimental infections, as an ABV isolate recovered from a bird with 
clinical PDD. We isolated a genotype 2 ABV from a cockatiel (CT15) with no evidence 
of PDD, however, the deaths of two CT15-challenged birds, at days 35 and 44, indicated 
that ABV2 is fully virulent under our challenge conditions. The onset of disease was 
more rapid (44 days compared to 64 to 111 days) than previously observed in 
experimental challenges with ABV4 isolates. Thus the observed differences in survival 
and lesions among ABV infected birds (both naturally and experimentally infected) are 
unlikely to be related simply to virus genotype, and may involve immune responses.  
There is clearly significant work to be done before we fully understand ABV-infection 
of psittacines. 
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